<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Lamotrigine for chronic neuropathic pain and fibromyalgia in adults - Wiffen, PJ - 2013 | Cochrane Library</title> <meta content="Lamotrigine for chronic neuropathic pain and fibromyalgia in adults - Wiffen, PJ - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006044.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Lamotrigine for chronic neuropathic pain and fibromyalgia in adults - Wiffen, PJ - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006044.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006044.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Lamotrigine for chronic neuropathic pain and fibromyalgia in adults" name="citation_title"/> <meta content="Philip J Wiffen" name="citation_author"/> <meta content="pwiffen@oxfordsrs.org.uk" name="citation_author_email"/> <meta content="Sheena Derry" name="citation_author"/> <meta content="R Andrew Moore" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD006044.pub4" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/12/03" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006044.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006044.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006044.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Disease; Analgesics [*therapeutic use]; Anticonvulsants [therapeutic use]; Chronic Disease; Fibromyalgia [*drug therapy]; Lamotrigine; Neuralgia [*drug therapy]; Randomized Controlled Trials as Topic; Triazines [*therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006044.pub4&amp;doi=10.1002/14651858.CD006044.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="6XSHdtL3";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006044\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006044\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006044\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006044\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006044.pub4",title:"Lamotrigine for chronic neuropathic pain and fibromyalgia in adults",firstPublishedDate:"Dec 3, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pain, Palliative and Supportive Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6XSHdtL3&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006044.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006044.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006044.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006044.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006044.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006044.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006044.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006044.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006044.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006044.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6740 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006044.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/full#CD006044-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/full#CD006044-sec-0081"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/full#CD006044-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/full#CD006044-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/full#CD006044-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/full#CD006044-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/full#CD006044-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/full#CD006044-sec-0075"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/appendices#CD006044-sec-0086"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/table_n/CD006044StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/table_n/CD006044StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Lamotrigine for chronic neuropathic pain and fibromyalgia in adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/information#CD006044-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Philip J Wiffen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/information#CD006044-cr-0003">Sheena Derry</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006044.pub4/information#CD006044-cr-0004">R Andrew Moore</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/information/en#CD006044-sec-0095">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 03 December 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006044.pub4">https://doi.org/10.1002/14651858.CD006044.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006044-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006044-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006044-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006044-abs-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006044-abs-0008">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006044-abs-0001" lang="en"> <section id="CD006044-sec-0001"> <h3 class="title" id="CD006044-sec-0001">Background</h3> <p>This is an update of the original Cochrane review entitled <i>Lamotrigine for acute and chronic pain</i> published in Issue 2, 2007, and updated in Issue 2, 2011. Some antiepileptic medicines have a place in the treatment of neuropathic pain (pain due to nerve damage). This updated review adds no new additional studies looking at evidence for lamotrigine as an effective treatment for chronic neuropathic pain or fibromyalgia. The update uses higher standards of evidence than previously. </p> </section> <section id="CD006044-sec-0002"> <h3 class="title" id="CD006044-sec-0002">Objectives</h3> <p> To assess the analgesic efficacy of lamotrigine in the treatment of chronic neuropathic pain and fibromyalgia, and to evaluate adverse effects reported in the studies. </p> </section> <section id="CD006044-sec-0003"> <h3 class="title" id="CD006044-sec-0003">Search methods</h3> <p>We identified randomised controlled trials (RCTs) of lamotrigine for chronic neuropathic pain and fibromyalgia (including cancer pain) from MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials (CENTRAL). We ran searches for the original review in 2006, in 2011 for the first update, and subsequent searches in August 2013 for this update. We sought additional studies from the reference lists of the retrieved papers. The original review and first update included acute pain, but no acute pain studies were identified. </p> </section> <section id="CD006044-sec-0004"> <h3 class="title" id="CD006044-sec-0004">Selection criteria</h3> <p>RCTs investigating the use of lamotrigine (any dose, by any route, and for any study duration) for the treatment of chronic neuropathic pain or fibromyalgia. Assessment of pain intensity or pain relief, or both, using validated scales. Participants were adults aged 18 and over. We included only full journal publication articles. </p> </section> <section id="CD006044-sec-0005"> <h3 class="title" id="CD006044-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted efficacy and adverse event data, and examined issues of study quality. We performed analysis using three tiers of evidence. The first tier used data where studies reported the outcome of at least 50% pain reduction from baseline, lasted at least eight weeks, had a parallel group design, included 200 or more participants in the comparison, and reported an intention‐to‐treat analysis. First‐tier studies did not use last observation carried forward (LOCF) or other imputational methods for dropouts. The second tier used data that failed to meet this standard and second‐tier results were therefore subject to potential bias. </p> </section> <section id="CD006044-sec-0006"> <h3 class="title" id="CD006044-sec-0006">Main results</h3> <p>Twelve included studies in 11 publications (1511 participants), all with chronic neuropathic pain: central post‐stroke pain (1), chemotherapy‐induced neuropathic pain (1), diabetic neuropathy (4), HIV‐related neuropathy (2), mixed neuropathic pain (2), spinal cord injury‐related pain (1), and trigeminal neuralgia (1). We did not identify any additional studies. Participants were aged between 26 and 77 years. Study duration was two weeks in one study and at least six weeks in the remainder; eight were of eight‐week duration or longer. </p> <p>No study provided first‐tier evidence for an efficacy outcome. There was no convincing evidence that lamotrigine is effective in treating neuropathic pain and fibromyalgia at doses of 200 mg to 400 mg daily. Almost 10% of participants taking lamotrigine reported a skin rash. </p> </section> <section id="CD006044-sec-0007"> <h3 class="title" id="CD006044-sec-0007">Authors' conclusions</h3> <p>Large, high‐quality, long‐duration studies reporting clinically useful levels of pain relief for individual participants provided no convincing evidence that lamotrigine is effective in treating neuropathic pain and fibromyalgia at doses of about 200 to 400 mg daily. Given the availability of more effective treatments including antiepileptics and antidepressant medicines, lamotrigine does not have a significant place in therapy based on the available evidence. The adverse effect profile of lamotrigine is also of concern. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006044-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006044-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006044-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006044-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD006044-abs-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006044-abs-0009">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006044-abs-0003" lang="en"> <h3>Lamotrigine (an antiepileptic drug) for chronic neuropathic pain or fibromyalgia</h3> <p>Neuropathic pain is pain coming from damaged nerves. It is different from pain messages carried along healthy nerves from damaged tissue (a fall, or cut, or arthritic knee). Neuropathic pain is treated by different medicines than pain from damaged tissue. Medicines like paracetamol or ibuprofen are not effective in neuropathic pain, while medicines that are sometimes used to treat depression or epilepsy can be very effective in some people with neuropathic pain. Our understanding of fibromyalgia (a condition of persistent, widespread pain and tenderness, sleep problems, and fatigue) is lacking, but fibromyalgia can respond to the same medicines as neuropathic pain. </p> <p>Lamotrigine is a medicine used to treat epilepsy, and so might be a useful medicine for neuropathic pain or fibromyalgia. </p> <p>On 26 November 2013 we performed searches to look for clinical trials where lamotrigine was used to treat neuropathic pain or fibromyalgia. We found 12 studies of reasonable quality that tested lamotrigine against placebo for a number of weeks. Almost half of the 1511 people in the studies had painful limbs because of damaged nerves caused by diabetes, and seven different painful neuropathic conditions were examined. No studies looked at fibromyalgia. </p> <p>Lamotrigine did not help the pain, and was no different from placebo except in causing more side effects. Adverse events were more frequent with lamotrigine than placebo, with rash in 1 person in 27. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006044-sec-0081" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006044-sec-0081"></div> <h3 class="title" id="CD006044-sec-0082">Implications for practice</h3> <section id="CD006044-sec-0082"> <p>Based on current evidence, the routine use of lamotrigine is unlikely to be of benefit in the treatment of neuropathic pain, and there are more effective and safer medicines available (<a href="./references#CD006044-bbs2-0061" title="MooreRA , StraubeS , WiffenPJ , DerryS , McQuayHJ . Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] ">Moore 2009a</a>; <a href="./references#CD006044-bbs2-0067" title="MooreRA , WiffenPJ , DerryS , McQuayHJ . Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2011, Issue 3. [DOI: 10.1002/14651858.CD007938.pub2] ">Moore 2011a</a>). There may be a role for experimental use or in patients who have failed to obtain pain relief from other treatments. The incidence of skin rash is not trivial and must be considered before initiating therapy. </p> </section> <h3 class="title" id="CD006044-sec-0083">Implications for research</h3> <section id="CD006044-sec-0083"> <p>Reasonable levels of evidence exist for the benefit of other antiepileptic drugs and antidepressants in the treatment of chronic neuropathic pain. There is therefore probably no justification for further research given the lack of evidence for benefit from lamotrigine and the potential for harm due to skin rash, which can occasionally be serious. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006044-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006044-sec-0022"></div> <div class="table" id="CD006044-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Lamotrigine 200 to 400 mg versus placebo for neuropathic pain</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Lamotrigine compared with placebo for painful diabetic neuropathy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: neuropathic pain (three studies in painful diabetic neuropathy)</b> </p> <p><b>Settings: Community</b> </p> <p><b>Intervention: oral lamotrigine 200 to 400 mg daily</b> </p> <p><b>Comparison: placebo</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Probable outcome with</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Risk ratio</b> </p> <p><b>NNTor NNH</b> </p> <p><b>(95% CI)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of studies, attacks, events</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>comparator</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>intervention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At least 50% of maximum pain relief</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>240 in 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>260 in 1000</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.1 (0.82 to 1.4)</p> <p>NNT not calculated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 studies, 773 participants, 195 events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unlikely that further research would reveal significant benefit, especially as potential high positive bias exists in the calculations we have because of LOCF imputation or completer analyses </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants with at least 1 adverse event (all conditions)</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>622 in 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>717 in 1000</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.1 (1.01 to 1.2)</p> <p>NNH 10 (6.5 to 27)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 studies, 1121 participants, 768 events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Large numbers of events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants with a serious adverse event (all conditions)</p> </td> <td align="center" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants with rash (all conditions)</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>56 in 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>95 in 1000</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.4 (1.01 to 2.0)</p> <p>NNH 27 (16 to 89)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 studies, 1715 participants, 138 events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modest number of events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Deaths (all conditions)</p> </td> <td align="center" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>LOCF: last observation carried forward; NNT: number needed to treat for an additional beneficial outcome: NNH: number needed to treat for an additional harmful outcome; RR: risk ratio </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006044-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006044-sec-0023"></div> <p>This is an update of a review first published in 2007 (<a href="./references#CD006044-bbs2-0093" title="WiffenPJ , ReesJ . Lamotrigine for acute and chronic pain. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD006044.pub2] ">Wiffen 2007</a>), which looked at lamotrigine to treat acute and chronic pain of any type. In 2011 we updated the review with the addition of five new studies (1111 participants, of whom 767 received lamotrigine), using stricter methodological criteria to reduce potential bias (<a href="./references#CD006044-bbs2-0094" title="WiffenPJ , DerryS , MooreRA . Lamotrigine for acute and chronic pain. Cochrane Database of Systematic Reviews2011, Issue 2. [DOI: 10.1002/14651858.CD006044.pub3] ">Wiffen 2011a</a>). We made the decision to update again, and to concentrate on chronic neuropathic pain and fibromyalgia. We changed the title from <i>Lamotrigine for acute and chronic pain</i>, because there have been further recent advances in the rigour with which we assess studies and report data. We also made this decision in order to conform with other reviews in the series on neuropathic pain and fibromyalgia, and because there is little or no use or intended use of lamotrigine and similar drugs in acute pain, or other forms of chronic pain. </p> <p>In particular we considered study size and duration, outcomes reported, and method of imputation for withdrawals, and we now report results in two tiers according to outcome and freedom from known sources of bias. We wanted to bring this review in line with a template protocol so that it could easily be included in the overview of antiepileptics for chronic neuropathic pain and fibromyalgia in adults (<a href="./references#CD006044-bbs2-0088" title="WiffenPJ , DerryS , MooreRA , AldingtonD , ColeP , RiceASC , et al. Antiepileptic drugs for neuropathic pain and fibromyalgia. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD010567] ">Wiffen 2013a</a>). Reviews of carbamazepine (<a href="./references#CD006044-bbs2-0087" title="WiffenPJ , DerryS , MooreRA , McQuayHJ . Carbamazepine for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD005451.pub2] ">Wiffen 2011b</a>), clonazepam (<a href="./references#CD006044-bbs2-0031" title="CorriganR , DerryS , WiffenPJ , MooreRA . Clonazepam for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2012, Issue 5. [DOI: 10.1002/14651858.CD009486.pub2] ">Corrigan 2012</a>), gabapentin (<a href="./references#CD006044-bbs2-0067" title="MooreRA , WiffenPJ , DerryS , McQuayHJ . Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2011, Issue 3. [DOI: 10.1002/14651858.CD007938.pub2] ">Moore 2011a</a>), lacosamide (<a href="./references#CD006044-bbs2-0041" title="HearnL , DerryS , MooreRA . Lacosamide for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD009318.pub2] ">Hearn 2012</a>), phenytoin (<a href="./references#CD006044-bbs2-0028" title="BirseF , DerryS , MooreRA . Phenytoin for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2012, Issue 5. [DOI: 10.1002/14651858.CD009485.pub2] ">Birse 2012</a>), pregabalin (<a href="./references#CD006044-bbs2-0061" title="MooreRA , StraubeS , WiffenPJ , DerryS , McQuayHJ . Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] ">Moore 2009a</a>), topiramate (<a href="./references#CD006044-bbs2-0089" title="WiffenPJ , DerryS , LunnMPT , MooreRA . Topiramate for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2013, Issue 8. [DOI: 10.1002/14651858.CD008314.pub3] ">Wiffen 2013b</a>), and valproic acid (<a href="./references#CD006044-bbs2-0038" title="GillD , DerryS , WiffenPJ , MooreRA . Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2011, Issue 10. [DOI: 10.1002/14651858.CD009183.pub2] ">Gill 2011</a>) have been completed. </p> <p>The aim is for all reviews to use the same methods, based on new criteria for what constitutes reliable evidence in chronic pain (<a href="./references#CD006044-bbs2-0063" title='MooreRA , EcclestonC , DerryS , WiffenP , BellRF , StraubeS , et al. "Evidence" in chronic pain‐‐establishing best practice in the reporting of systematic reviews. Pain2010;150(3):386‐9. [DOI: 10.1016/j.pain.2010.05.011] '>Moore 2010a</a>; <a href="./references#CD006044-bbs2-0071" title="MooreRA , StraubeS , EcclestonC , DerryS , AldingtonD , WiffenP , et al. Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain2012;153(2):265‐8. [DOI: 10.1016/j.pain.2011.10.004] ">Moore 2012b</a>; <a href="./appendices#CD006044-sec-0087">Appendix 1</a>). A Cochrane review of pregabalin in neuropathic pain and fibromyalgia demonstrated different response rates for different types of chronic pain (higher in diabetic neuropathy and postherpetic neuralgia and lower in central pain and fibromyalgia) (<a href="./references#CD006044-bbs2-0061" title="MooreRA , StraubeS , WiffenPJ , DerryS , McQuayHJ . Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] ">Moore 2009a</a>). This indicated that different neuropathic pain conditions should be treated separately from one another, and that pooling should not be done unless there are good grounds for doing so. While fibromyalgia is considered to have a different aetiology from chronic neuropathic pain, it is a condition that responds to the same therapies. Because of limitations in the number of available clinical trials, it is convenient to consider fibromyalgia together with neuropathic pain. We make no presumption to pool data across individual neuropathic pain conditions or fibromyalgia, but will consider each condition separately. </p> <section id="CD006044-sec-0024"> <h3 class="title" id="CD006044-sec-0024">Description of the condition</h3> <p>The 2011 International Association for the Study of Pain definition of <i>neuropathic pain</i> is "pain caused by a lesion or disease of the somatosensory system" (<a href="./references#CD006044-bbs2-0047" title="JensenTS , BaronR , HaanpääM , KalsoE , LoeserJD , RiceAS , et al. A new definition of neuropathic pain. Pain2011; Vol. 152, issue 10:2204‐5. [DOI: 10.1016/j.pain.2011.06.017] ">Jensen 2011</a>) based on an earlier consensus meeting (<a href="./references#CD006044-bbs2-0086" title="TreedeRD , JensenTS , CampbellJN , CruccuG , DostrovskyJO , GriffinJW , et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology2008;70(18):1630‐5. ">Treede 2008</a>). Neuropathic pain may be caused by nerve damage, but is often followed by changes in the central nervous system (CNS) (<a href="./references#CD006044-bbs2-0059" title="MoissetX , BouhassiraD . Brain imaging of neuropathic pain. Neuroimaging2007;37(Suppl 1):S80‐8. ">Moisset 2007</a>). Neuropathic pain tends to be chronic and may be present for months or years. It is complex (<a href="./references#CD006044-bbs2-0025" title="ApkarianAV , HashmiJA , BalikiMN . Pain and the brain: specificity and plasticity of the brain in clinical chronic pain. Pain2011;152(3 Suppl):S49‐64. [DOI: 10.1016/j.pain.2010.11.010] ">Apkarian 2011</a>; <a href="./references#CD006044-bbs2-0085" title="TraceyI . Can neuroimaging studies identify pain endophenotypes in humans?. Nature Reviews Neurology2011;7(3):173‐81. [doi: 10.1038/nrneurol.2011.4] ">Tracey 2011</a>), and neuropathic pain features can be found in patients with joint pain (<a href="./references#CD006044-bbs2-0079" title="SoniA , BatraR , GwilymS , SpectorT , HartD , ArdenN , et al. Neuropathic features of joint pain: a community‐based study. Arthritis &amp; Rheumatism2013;April 1:Epub ahead of print. [DOI: 10.1002/art.37962] ">Soni 2013</a>). </p> <p><i>Fibromyalgia</i> is defined as widespread pain for longer than three months with pain on palpation at 11 or more of 18 specified tender points (<a href="./references#CD006044-bbs2-0090" title="WolfeF , SmytheHA , YunusMB , BennettRM , BombardierC , GoldenbergDL , et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis and Rheumatism1990;33(2):160‐72. ">Wolfe 1990</a>), and is frequently associated with other symptoms such as poor sleep, fatigue, and depression. More recently, a definition of fibromyalgia has been proposed based on symptom severity and the presence of widespread pain (<a href="./references#CD006044-bbs2-0091" title="WolfeF , ClauwDJ , FitzcharlesMA , GoldenbergDL , KatzRS , MeaseP , et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care and Research2010;62(5):600‐10. [DOI: 10.1002/acr.20140] ">Wolfe 2010</a>). The cause, or causes, are not well understood, but it has features in common with neuropathic pain, including changes in the CNS. Moreover, patients with neuropathic pain and those with fibromyalgia experience similar sensory phenomena (<a href="./references#CD006044-bbs2-0052" title="KoroschetzJ , RehmSE , GockelU , BroszM , FreynhagenR , TölleTR , et al. Fibromyalgia and neuropathic pain－differences and similarities: a comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia. BMC Neurology2011;11:55. [DOI: 10.1186/1471‐2377‐11‐55] ">Koroschetz 2011</a>). Many people with these conditions are significantly disabled with moderate or severe pain for many years. </p> <p>In primary care in the United Kingdom (UK), the incidences per 100,000 person‐years' observation have been reported as 28 (95% confidence interval (CI) 27 to 30) for postherpetic neuralgia, 27 (26 to 29) for trigeminal neuralgia, 0.8 (0.6 to 1.1) for phantom limb pain, and 21 (20 to 22) for painful diabetic neuropathy (<a href="./references#CD006044-bbs2-0040" title="HallGC , CarrollD , McQuayHJ . Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002‐2005. BMC Family Practice2008;9:26. [DOI: 10.1186/1471‐2296‐9‐26] ">Hall 2008</a>). Estimates varied between studies, often because of small numbers of cases. The incidence of trigeminal neuralgia has been estimated at 4 in 100,000 per year (<a href="./references#CD006044-bbs2-0048" title="KatusicS , WilliamsDB , BeardCM , BergstralhEJ , KurlandLT . Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota,1945‐1984. Neuroepidemiology1991;10(5‐6):276‐81. ">Katusic 1991</a>; <a href="./references#CD006044-bbs2-0077" title="RappaportZH , DevorM . Trigeminal neuralgia: the role of self‐sustaining discharge in the trigeminal ganglion. Pain1994;56(2):127‐38. [DOI: 10.1016/0304‐3959(94)90086‐8] ">Rappaport 1994</a>), while more recently, a study of facial pain in The Netherlands found incidences per 100,000 person‐years of 12.6 for trigeminal neuralgia and 3.9 for postherpetic neuralgia (<a href="./references#CD006044-bbs2-0051" title="KoopmanJS , DielemanJP , HuygenFJ , DeMosM , MartinCG , SturkenboomMC . Incidence of facial pain in the general population. Pain2009;147(1‐3):122‐7. [DOI: 10.1016/j.pain.2009.08.023] ">Koopman 2009</a>). A systematic review of chronic pain demonstrated that some neuropathic pain conditions, such as painful diabetic neuropathy, can be more common, with prevalence rates up to 400 per 100,000 person‐years (<a href="./references#CD006044-bbs2-0058" title="McQuayHJ , SmithLA , MooreRA . Chronic Pain. In: StevensA , RafteryJ , MantJ , SimpsonS editor(s). Health Care Needs Assessment. 3rd Edition. Oxford: Radcliffe Publishing, 2007. ">McQuay 2007</a>). The prevalence of neuropathic pain was reported as being 3.3% in Austria (<a href="./references#CD006044-bbs2-0039" title="GustorffB , DornerT , LikarR , GrisoldW , LawrenceK , SchwarzF , et al. Prevalence of self‐reported neuropathic pain and impact on quality of life: a prospective representative survey. Acta Anaesthesiologica Scandinavica2008;52(1):132‐6. [DOI: 10.1111/j.1399‐6576.2007.01486.x] ">Gustorff 2008</a>), 6.9% in France (<a href="./references#CD006044-bbs2-0029" title="BouhassiraD , Lantéri‐MinetM , AttalN , LaurentB , TouboulC . Prevalence of chronic pain with neuropathic characteristics in the general population. Pain2008;136(3):380‐7. [DOI: 10.1016/j.pain.2007.08.013] ">Bouhassira 2008</a>) and as high as 8% in the UK (<a href="./references#CD006044-bbs2-0084" title="TorranceN , SmithBH , BennettMI , LeeAJ . The epidemiology of chronic pain of predominantly neuropathic origin: results from a general population survey. Journal of Pain2006;7(4):281‐9. [DOI: 10.1016/j.jpain.2005.11.008] ">Torrance 2006</a>), and about 7% in a systematic review of studies published since 2000 (<a href="./references#CD006044-bbs2-0072" title="MooreRA , DerryS , TaylorRS , StraubeS , PhillipsCJ . The costs and consequences of adequately managed chronic non‐cancer pain and chronic neuropathic pain. Pain Practice2013;March 6:Epub ahead of print. [DOI: 10.1111/papr.12050] ">Moore 2013a</a>). Some forms of neuropathic pain, such as diabetic neuropathy and post surgical chronic pain (which is often neuropathic in origin) are increasingly common (<a href="./references#CD006044-bbs2-0040" title="HallGC , CarrollD , McQuayHJ . Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002‐2005. BMC Family Practice2008;9:26. [DOI: 10.1186/1471‐2296‐9‐26] ">Hall 2008</a>). Fibromyalgia is common, especially in women, with an all‐age prevalence of 12%, and a female to male ratio of 6:1 (<a href="./references#CD006044-bbs2-0056" title="McNallyJD , MathesonDA , BakowskyVS . The epidemiology of self‐reported fibromyalgia in Canada. Chronic Diseases in Canada2006;27(1):9‐16. ">McNally 2006</a>). </p> <p>Neuropathic pain and fibromyalgia are known to be difficult to treat effectively, with only a minority of individuals experiencing a clinically relevant benefit from any one intervention. A multidisciplinary approach is now advocated, with pharmacological interventions being combined with physical or cognitive interventions or both. Conventional analgesics are usually not effective. Some patients with neuropathic pain may derive some benefit from topical lidocaine patch or low concentration topical capsaicin, although evidence of benefit is uncertain (<a href="./references#CD006044-bbs2-0032" title="DerryS , MooreRA . Topical capsaicin (low concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD010111] ">Derry 2012</a>; <a href="./references#CD006044-bbs2-0049" title="KhaliqW , AlamS , PuriN . Topical lidocaine for the treatment of postherpetic neuralgia [withdrawn]. Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD004846.pub2] ">Khaliq 2013</a>). High concentration topical capsaicin may benefit some patients with postherpetic neuralgia (<a href="./references#CD006044-bbs2-0033" title="DerryS , Sven‐RiceA , ColeP , TanT , MooreRA . Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD007393.pub3] ">Derry 2013</a>). Treatment is more usually by so‐called unconventional analgesics such as antidepressants like duloxetine and amitriptyline (<a href="./references#CD006044-bbs2-0054" title="LunnMP , HughesRA , WiffenPJ . Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD007115.pub2] ">Lunn 2009</a>; <a href="./references#CD006044-bbs2-0070" title="MooreRA , DerryS , AldingtonD , ColeP , WiffenPJ . Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD008242.pub2] ">Moore 2012a</a>; <a href="./references#CD006044-bbs2-0083" title="SultanA , GaskellH , DerryS , MooreRA . Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurology2008;8:29. [DOI: 10.1186/1471‐2377‐8‐29] ">Sultan 2008</a>) or antiepileptics like gabapentin or pregabalin (<a href="./references#CD006044-bbs2-0061" title="MooreRA , StraubeS , WiffenPJ , DerryS , McQuayHJ . Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] ">Moore 2009a</a>; <a href="./references#CD006044-bbs2-0067" title="MooreRA , WiffenPJ , DerryS , McQuayHJ . Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2011, Issue 3. [DOI: 10.1002/14651858.CD007938.pub2] ">Moore 2011a</a>). The proportion of patients who achieve worthwhile pain relief (typically defined as at least 50% pain intensity reduction (<a href="./references#CD006044-bbs2-0073" title="MooreRA , StraubeS , AldingtonD . Pain measures and cut‐offs－'no worse than mild pain' as a simple, universal outcome. Anaesthesia2013;68(4):400‐12. [DOI: 10.1111/anae.12148] ">Moore 2013b</a>)) is small, typically 10% to 25% more than with placebo, with numbers needed to treat for an additional beneficial outcome (NNTs) usually between 4 and 10. </p> </section> <section id="CD006044-sec-0025"> <h3 class="title" id="CD006044-sec-0025">Description of the intervention</h3> <p>Lamotrigine, a phenyltriazine, is chemically unrelated to other antiepileptic drugs. The drug is available as standard oral tablets (25 mg to 200 mg) and chewable, dispersible tablets (2 mg to 100 mg), and a new extended release tablet is available in some parts of the world. </p> </section> <section id="CD006044-sec-0026"> <h3 class="title" id="CD006044-sec-0026">How the intervention might work</h3> <p>Lamotrigine is an antiepileptic drug exerting its antiepileptic effect via sodium channels. There is some evidence that agents that block sodium channels are useful in the treatment of neuropathic pain (<a href="./references#CD006044-bbs2-0055" title="McCleaneGJ . Lamotrigine in the management of neuropathic pain. The Clinical Journal of Pain2000;16:321‐6. ">McCleane 2000</a>). There is evidence from animal models supporting the use of lamotrigine in neuropathic pain, and for an effect in experimental pain models such as cold‐induced pain in humans (<a href="./references#CD006044-bbs2-0055" title="McCleaneGJ . Lamotrigine in the management of neuropathic pain. The Clinical Journal of Pain2000;16:321‐6. ">McCleane 2000</a>). Lamotrigine is chemically unrelated to existing antiepileptic agents. There has also been discussion of the role of lamotrigine as a pre‐emptive analgesic to reduce postsurgical pain (<a href="./references#CD006044-bbs2-0013" title="BonicalziV , CanaveroS , CeruttiF , PiazzaM , ClementeM , ChioA . Lamotrigine reduces total postoperative analgesic requirement: a randomized double‐blind, placebo‐controlled pilot study. Surgery1997;122(3):567‐70. [DOI: 10.1016/S0039‐6060(97)90129‐X] ">Bonicalzi 1997</a>). More recently it has been shown that neuronal alpha4 beta2 nicotinic acetylcholine receptors may be a target for lamotrigine, and this may mediate its antiepileptic effects (<a href="./references#CD006044-bbs2-0092" title="ZhengC , YangK , LiuQ , WangMY , ShenJ , VallesSA , et al. The anticonvulsive drug lamotrigine blocks neuronal{alpha}4{beta}2‐nicotinic acetylcholine receptors. The Journal of Pharmacology and Experimental Therapeutics2010;Aug 5:Epub ahead of print. [DOI: 10.1124/jpet.110.171108] ">Zheng 2010</a>). </p> </section> <section id="CD006044-sec-0027"> <h3 class="title" id="CD006044-sec-0027">Why it is important to do this review</h3> <p>The standards used to assess evidence in chronic pain trials have changed substantially in recent years, with particular attention being paid to trial duration, withdrawals, and statistical imputation following withdrawal, all of which can substantially alter estimates of efficacy. The most important change is the move from using average pain scores, or average change in pain scores, to using the number of participants who have a large decrease in pain (by at least 50%); this level of pain relief has been shown to correlate with improvements in comorbid symptoms, function, and quality of life. These standards are set out in the reference guide for pain studies (<a href="./references#CD006044-bbs2-0027" title="PaPaS author and referee guidance. papas.cochrane.org/papas‐documents (accessed 1 August 2013). ">AUREF 2012</a>) and reflect what patients with chronic pain want from treatment (<a href="./references#CD006044-bbs2-0072" title="MooreRA , DerryS , TaylorRS , StraubeS , PhillipsCJ . The costs and consequences of adequately managed chronic non‐cancer pain and chronic neuropathic pain. Pain Practice2013;March 6:Epub ahead of print. [DOI: 10.1111/papr.12050] ">Moore 2013a</a>). </p> <p>This Cochrane review assesses evidence in ways that make both statistical and clinical sense, and uses developing criteria for what constitutes reliable evidence in chronic pain (<a href="./references#CD006044-bbs2-0063" title='MooreRA , EcclestonC , DerryS , WiffenP , BellRF , StraubeS , et al. "Evidence" in chronic pain‐‐establishing best practice in the reporting of systematic reviews. Pain2010;150(3):386‐9. [DOI: 10.1016/j.pain.2010.05.011] '>Moore 2010a</a>). Trials included and analysed need to meet a minimum of reporting quality (blinding, randomisation), validity (duration, dose and timing, diagnosis, outcomes, etc), and size (ideally at least 500 participants in a comparison in which the NNT is four or more (<a href="./references#CD006044-bbs2-0060" title="MooreRA , GavaghanD , TramèrMR , CollinsSL , McQuayHJ . Size is everything ‐ large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain1998;78(3):209‐16. [DOI: 10.1016/S0304‐3959(98)00140‐7] ">Moore 1998</a>)). </p> <p>Lamotrigine is not widely prescribed for neuropathic pain, though it is prescribed for some cases of painful HIV‐related neuropathy. It is important to know its place in the range of drugs used to treat the various types of neuropathic pain. This updated review brings the evidence for lamotrigine into line with that for other medicines used in these conditions, and will form part of an overview of antiepileptic drugs for chronic neuropathic pain and fibromyalgia. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006044-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006044-sec-0028"></div> <p>To assess the analgesic efficacy of lamotrigine in the treatment of chronic neuropathic pain and fibromyalgia, and to evaluate adverse effects reported in the studies. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006044-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006044-sec-0029"></div> <section id="CD006044-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006044-sec-0031"> <h4 class="title">Types of studies</h4> <p>We included studies if they were randomised controlled trials (RCTs) with at least 10 participants per treatment group and double‐blind (participant and observers) assessment of participant‐reported outcomes, following two weeks of treatment or longer, although the emphasis of the review is on studies of six weeks or longer. We required full journal publication, with the exception of extended abstracts of otherwise unpublished clinical trials (for example, detailed information from PDFs of posters that typically included all important details of methodology used and results obtained). We did not include short abstracts (usually meeting reports with inadequate or no reporting of data). We excluded studies of experimental pain, case reports, and clinical observations. </p> <p>In the earlier review, we excluded studies of lamotrigine used to treat pain produced by other drugs; in this version we have included one study for chemotherapy‐induced pain, but have not combined results from this study in the analysis (<a href="./references#CD006044-bbs2-0005" title="RaoRD , FlynnPJ , SloanJA , WongGY , NovotnyP , JohnsonDB , et al. Efficacy of lamotrigine in the management of chemotherapy‐induced peripheral neuropathy: a phase 3 randomized, double‐blind, placebo‐controlled trial, N01C3. Cancer2008; Vol. 112:2802‐8. [DOI: 10.1002/cncr.23482] ">Rao 2008</a>). </p> </section> <section id="CD006044-sec-0032"> <h4 class="title">Types of participants</h4> <p>Studies included adult participants aged 18 years and above. Participants could have one or more of a wide range of chronic neuropathic pain conditions including (but not limited to): </p> <p> <ul id="CD006044-list-0001"> <li> <p>cancer‐related neuropathy;</p> </li> <li> <p>central neuropathic pain;</p> </li> <li> <p>complex regional pain syndrome (CRPS) Type II;</p> </li> <li> <p>human immunodeficiency virus (HIV) neuropathy;</p> </li> <li> <p>painful diabetic neuropathy;</p> </li> <li> <p>phantom limb pain;</p> </li> <li> <p>postherpetic neuralgia;</p> </li> <li> <p>postoperative or traumatic neuropathic pain;</p> </li> <li> <p>spinal cord injury;</p> </li> <li> <p>trigeminal neuralgia;</p> </li> </ul> </p> <p>and</p> <p> <ul id="CD006044-list-0002"> <li> <p>fibromyalgia;</p> </li> <li> <p>CRPS Type I.</p> </li> </ul> </p> </section> <section id="CD006044-sec-0033"> <h4 class="title">Types of interventions</h4> <p>Lamotrigine in any dose, by any route, administered for the relief of neuropathic pain or fibromyalgia, and compared to placebo, no intervention or any other active comparator. </p> </section> <section id="CD006044-sec-0034"> <h4 class="title">Types of outcome measures</h4> <p>We anticipated that studies would use a variety of outcome measures, with the majority of studies using standard subjective scales (numerical rating scale (NRS) or visual analogue scale (VAS)) for pain intensity or pain relief, or both. We were particularly interested in Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) definitions for moderate and substantial benefit in chronic pain studies (<a href="./references#CD006044-bbs2-0034" title="DworkinRH , TurkDC , WyrwichKW , BeatonD , CleelandCS , FarrarJT , et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. The Journal of Pain2008;9(2):105‐21. [DOI: 10.1016/j.jpain.2007.09.005] ">Dworkin 2008</a>). These are defined as at least 30% pain relief over baseline (moderate), at least 50% pain relief over baseline (substantial), much or very much improved on patient global impression of change (PGIC) (moderate), and very much improved on PGIC (substantial). These outcomes are different from those set out in the earlier review (<a href="./references#CD006044-bbs2-0093" title="WiffenPJ , ReesJ . Lamotrigine for acute and chronic pain. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD006044.pub2] ">Wiffen 2007</a>), concentrating as they do on dichotomous outcomes where pain responses do not follow a normal (Gaussian) distribution. People with chronic pain desire high levels of pain relief, ideally more than 50%, and with pain not worse than mild (<a href="./references#CD006044-bbs2-0075" title="O'BrienEM , StaudRM , HassingerAD , McCullochRC , CraggsJG , AtchisonJW , et al. Patient‐centered perspective on treatment outcomes in chronic pain. Pain Medicine2010;11(1):6‐15. [DOI: 10.1111/j.1526‐4637.2009.00685.x] ">O'Brien 2010</a>). </p> <p>We include a 'Summary of findings' table as set out in the Cochrane Pain, Palliative and Supportive Care Group author guide (<a href="./references#CD006044-bbs2-0027" title="PaPaS author and referee guidance. papas.cochrane.org/papas‐documents (accessed 1 August 2013). ">AUREF 2012</a>). The 'Summary of findings' table includes outcomes of at least 30% and at least 50% pain intensity reduction, PGIC, adverse event withdrawals, serious adverse events and death (<a href="./full#CD006044-tbl-0001">summary of findings Table for the main comparison</a>). </p> <section id="CD006044-sec-0035"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD006044-list-0003"> <li> <p>Participant‐reported pain intensity reduction of 30% or greater.</p> </li> <li> <p>Participant‐reported pain intensity reduction of 50% or greater.</p> </li> <li> <p>Participant‐reported global impression of clinical change (Patient Global Impression of Change, PGIC) much or very much improved. </p> </li> <li> <p>Participant‐reported global impression of clinical change (PGIC) very much improved.</p> </li> </ol> </p> </section> <section id="CD006044-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD006044-list-0004"> <li> <p>Any pain‐related outcome indicating some improvement.</p> </li> <li> <p>Withdrawals due to lack of efficacy.</p> </li> <li> <p>Participants experiencing any adverse event.</p> </li> <li> <p>Participants experiencing any serious adverse event.</p> </li> <li> <p>Withdrawals due to adverse events.</p> </li> <li> <p>Specific adverse events, particularly somnolence and dizziness.</p> </li> </ol> </p> <p>These outcomes are not eligibility criteria for this review, but are outcomes of interest within whichever studies are included. </p> </section> </section> </section> <section id="CD006044-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD006044-sec-0038"> <h4 class="title">Electronic searches</h4> <p>We identified studies by several methods. For the original review we identified RCTs of lamotrigine (and key brand names Lamictal, Lamictin, Neurium) in acute and chronic pain in the Cochrane Central Register of Controlled Trials (CENTRAL, 2010, Issue 12), MEDLINE (via Ovid) from 1966 to January 2011, and EMBASE (via Ovid) from 1994 to January 2011. </p> <p>For this update we searched for new studies in chronic neuropathic pain and fibromyalgia in: </p> <p> <ul id="CD006044-list-0005"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL, 2013, Issue 11 in <i>The Cochrane Library</i>); </p> </li> <li> <p>MEDLINE (via Ovid) (January 2010 to 26 November 2013);</p> </li> <li> <p>EMBASE (via Ovid) (January 2010 to 26 November 2013);</p> </li> <li> <p>PhRMA clinical study results database (<a href="http://www.clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>) to 26 November 2013; </p> </li> <li> <p>WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch" target="_blank">apps.who.int/trialsearch</a>) to 26 November 2013. </p> </li> </ul> </p> <p>Given the limited literature in this area, we undertook a sensitive search strategy. See <a href="./appendices#CD006044-sec-0088">Appendix 2</a> for the MEDLINE search strategy, <a href="./appendices#CD006044-sec-0089">Appendix 3</a> for the EMBASE search strategy, and <a href="./appendices#CD006044-sec-0090">Appendix 4</a> for the CENTRAL search strategy. </p> </section> <section id="CD006044-sec-0039"> <h4 class="title">Searching other resources</h4> <p>For the original review, we identified additional studies from the reference lists of the retrieved papers and by contacting study authors. We applied no language restrictions. </p> </section> </section> <section id="CD006044-sec-0040"> <h3 class="title" id="CD006044-sec-0040">Data collection and analysis</h3> <section id="CD006044-sec-0041"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently read the titles and abstracts of all studies identified by the search, and the full text of all potentially relevant studies. We reached agreement on eligibility by discussion. We did not anonymise the studies in any way before assessment. </p> </section> <section id="CD006044-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>Two review authors extracted data using a standard form, and agreed data before entry into Review Manager 5 (<a href="./references#CD006044-bbs2-0078" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>) or any other analysis method. Data extracted included information about the pain condition and number of participants treated, drug and dosing regimen, study design, study duration and follow‐up, analgesic outcome measures and results, withdrawals and adverse events (participants experiencing any adverse event or a serious adverse event). </p> </section> <section id="CD006044-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We independently scored each study for quality using a three‐item scale (<a href="./references#CD006044-bbs2-0045" title="JadadAR , MooreRA , CarrollD , JenkinsonC , ReynoldsDJM , GavaghanDJ , et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials1996;17(1):1‐12. [DOI: 10.1016/0197‐2456(95)00134‐4] ">Jadad 1996</a>) and agreed a 'consensus' score for each study. Scores of two and below have been associated with greater estimates of efficacy than studies of higher quality (<a href="./references#CD006044-bbs2-0050" title="KhanKS , DayaS , JadadA . The importance of quality of primary studies in producing unbiased systematic reviews. Archives of Internal Medicine1996;156(6):661‐6. ">Khan 1996</a>). Quality scores were not used to weight the results in any way. </p> <p>We used the 'Risk of bias' tool to assess the likely impact on the strength of the evidence of various study characteristics relating to methodological quality (randomisation, allocation concealment, blinding, freedom from selective reporting), study validity (duration, outcome reporting, and handling of missing data), and size (<a href="./references#CD006044-bbs2-0063" title='MooreRA , EcclestonC , DerryS , WiffenP , BellRF , StraubeS , et al. "Evidence" in chronic pain‐‐establishing best practice in the reporting of systematic reviews. Pain2010;150(3):386‐9. [DOI: 10.1016/j.pain.2010.05.011] '>Moore 2010a</a>). </p> <p>Two review authors independently assessed risks of bias for each study, using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006044-bbs2-0043" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration. ">Higgins 2011</a>) and adapted from those used by the Cochrane Pregnancy and Childbirth Group, with any disagreements resolved by discussion. We assessed the following for each study. </p> <p> <ul id="CD006044-list-0006"> <li> <p>Random sequence generation (checking for possible selection bias). We assessed the method used to generate the allocation sequence as: low risk of bias (any truly random process, eg random number table; computer random number generator); unclear risk of bias (method used to generate sequence not clearly stated). We excluded studies using a non‐random process (eg odd or even date of birth; hospital or clinic record number). </p> </li> <li> <p>Allocation concealment (checking for possible selection bias). The method used to conceal allocation to interventions before assignment determines whether intervention allocation could have been foreseen in advance of or during recruitment, or changed after assignment. We assessed the methods as: low risk of bias (eg telephone or central randomisation; consecutively numbered sealed opaque envelopes); unclear risk of bias (method not clearly stated). We excluded studies that did not conceal allocation (eg open list). </p> </li> <li> <p>Blinding of outcome assessment (checking for possible detection bias). We assessed the methods used to blind study participants and outcome assessors from knowledge of which intervention a participant received. We assessed the methods as: low risk of bias (study states that it was blinded and describes the method used to achieve blinding, eg identical tablets; matched in appearance and smell); unclear risk of bias (study states that it was blinded but does not provide an adequate description of how this was achieved). We excluded studies that were not double‐blind. </p> </li> <li> <p>Incomplete outcome data (checking for possible attrition bias due to the amount, nature, and handling of incomplete outcome data). We assessed the methods used to deal with incomplete data as: low risk of bias (&lt; 10% of participants did not complete the study, or used ‘baseline observation carried forward’ analysis, or both); unclear risk of bias (used 'last observation carried forward' (LOCF) analysis); high risk of bias (used 'completer' analysis). </p> </li> <li> <p>Size of study (checking for possible biases confounded by small size). We assessed studies as being at low risk of bias (≥ 200 participants per treatment arm); unclear risk of bias (50 to 199 participants per treatment arm); high risk of bias (&lt; 50 participants per treatment arm). </p> </li> </ul> </p> </section> <section id="CD006044-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <p>We used the risk ratio (relative risk, RR) to establish statistical difference. We used numbers needed to treat for an additional beneficial outcome (NNT) or for an additional harmful outcome (NNH) and pooled percentages as absolute measures of benefit or harm. </p> <p>The following terms are used to describe adverse outcomes in terms of harm or prevention of harm: </p> <p> <ul id="CD006044-list-0007"> <li> <p>When significantly fewer adverse outcomes occurred with lamotrigine than with control (placebo or active) we used the term the number needed to treat to prevent one event (NNTp); </p> </li> <li> <p>When significantly more adverse outcomes occurred with lamotrigine compared with control (placebo or active) we used the term the number needed to harm or cause one event (NNH). </p> </li> </ul> </p> </section> <section id="CD006044-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <p>The control treatment arm would be split between active treatment arms in a single study if the active treatment arms were not combined for analysis. </p> </section> <section id="CD006044-sec-0046"> <h4 class="title">Dealing with missing data</h4> <p>We used intention‐to‐treat (ITT) analysis. The ITT population consisted of participants who were randomised, took the assigned study medication and provided at least one post‐baseline assessment. Missing participants were assigned zero improvement where this could be done. We were aware that imputation methods might be problematical and examined trial reports for information about them. </p> </section> <section id="CD006044-sec-0047"> <h4 class="title">Assessment of heterogeneity</h4> <p>We dealt with clinical heterogeneity by combining studies that examined similar painful conditions, and not combining results from dissimilar painful conditions. We assessed statistical heterogeneity visually (<a href="./references#CD006044-bbs2-0053" title="L'AbbéKA , DetskyAS , O'RourkeK . Meta‐analysis in clinical research. Annals of Internal Medicine1987;107(2):224‐33. ">L'Abbe 1987</a>) and with the use of the I² statistic (<a href="./references#CD006044-bbs2-0042" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>). </p> </section> <section id="CD006044-sec-0048"> <h4 class="title">Assessment of reporting biases</h4> <p>The aim of this review was to use dichotomous data of known utility (<a href="./references#CD006044-bbs2-0063" title='MooreRA , EcclestonC , DerryS , WiffenP , BellRF , StraubeS , et al. "Evidence" in chronic pain‐‐establishing best practice in the reporting of systematic reviews. Pain2010;150(3):386‐9. [DOI: 10.1016/j.pain.2010.05.011] '>Moore 2010a</a>). The review did not depend on what authors of the original studies chose to report or not report, though clearly there were difficulties with studies failing to report any dichotomous results. We extracted continuous data, which probably poorly reflected efficacy and utility, and used them only when useful for illustrative purposes. </p> <p>We undertook no statistical assessment of publication bias.</p> </section> <section id="CD006044-sec-0049"> <h4 class="title">Data synthesis</h4> <p>We considered individual painful conditions separately because placebo response rates with the same outcome can vary between conditions, as can the drug‐specific effects (<a href="./references#CD006044-bbs2-0061" title="MooreRA , StraubeS , WiffenPJ , DerryS , McQuayHJ . Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] ">Moore 2009a</a>). </p> <p>We analysed data for each painful condition in three tiers, according to outcome and freedom from known sources of bias. </p> <p> <ul id="CD006044-list-0008"> <li> <p>The first tier uses data meeting current best standards, where studies report the outcome of at least 50% pain intensity reduction over baseline (or its equivalent), without the use of last observation carried forward (LOCF) or other imputation method for dropouts, report an intention‐to‐treat (ITT) analysis, last eight or more weeks, have a parallel‐group design, and have at least 200 participants (preferably at least 400) in the comparison (<a href="./references#CD006044-bbs2-0063" title='MooreRA , EcclestonC , DerryS , WiffenP , BellRF , StraubeS , et al. "Evidence" in chronic pain‐‐establishing best practice in the reporting of systematic reviews. Pain2010;150(3):386‐9. [DOI: 10.1016/j.pain.2010.05.011] '>Moore 2010a</a>; <a href="./references#CD006044-bbs2-0071" title="MooreRA , StraubeS , EcclestonC , DerryS , AldingtonD , WiffenP , et al. Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain2012;153(2):265‐8. [DOI: 10.1016/j.pain.2011.10.004] ">Moore 2012b</a>). These top‐tier results are reported first. </p> </li> <li> <p>The second tier uses data from at least 200 participants but where one or more of the above conditions is not met (for example reporting at least 30% pain intensity reduction, using LOCF or a completer analysis, or lasting four to eight weeks). </p> </li> <li> <p>The third tier of evidence relates to data from fewer than 200 participants, or where there are expected to be significant problems because, for example, of very short duration studies of less than four weeks, where there is major heterogeneity between studies, or where there are shortcomings in allocation concealment, attrition, or incomplete outcome data. For this third tier of evidence, no data synthesis is reasonable, and may be misleading, but an indication of beneficial effects might be possible. </p> </li> </ul> </p> <p>We used dichotomous data to calculate risk ratio for benefit with 95% confidence intervals (CIs), using a fixed‐effect model, together with numbers needed to treat for an additional beneficial outcome (NNTs) (<a href="./references#CD006044-bbs2-0030" title="CookRJ , SackettDL . The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995;3101995;310(6977):452‐4. ">Cook 1995</a>). This was done for effectiveness, for adverse effects, and for drug‐related study withdrawal. We also undertook meta‐analysis when appropriate data were available. We calculated NNTs as the reciprocal of the absolute risk reduction (<a href="./references#CD006044-bbs2-0057" title="McQuayH , MooreR . An evidence‐based resource for pain relief. Oxford: Oxford University Press, 1998. [ISBN: 0‐19‐263048‐2] ">McQuay 1998</a>). For unwanted effects, the NNH (number needed to treat for an additional harmful outcome) is calculated in the same way. In the absence of dichotomous data, we have reported summary continuous data where available and appropriate, but did not carry out any analysis. We undertook meta‐analysis using a fixed‐effect model. </p> </section> <section id="CD006044-sec-0050"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned no subgroup analyses, beyond separate analysis of different conditions, as we expected that there would be insufficient study data. </p> </section> <section id="CD006044-sec-0051"> <h4 class="title">Sensitivity analysis</h4> <p>We planned no sensitivity analyses because we knew the evidence base to be too small to allow reliable analysis. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006044-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006044-sec-0052"></div> <section id="CD006044-sec-0053"> <h3 class="title">Description of studies</h3> <section id="CD006044-sec-0054"> <h4 class="title">Results of the search</h4> <p>The previous review identified 23 studies, in 23 publications. New searches for this update identified one potentially relevant study. </p> </section> <section id="CD006044-sec-0055"> <h4 class="title">Included studies</h4> <p>There were seven studies (400 participants) in the original review (<a href="./references#CD006044-bbs2-0001" title="EisenbergE , LurieY , BrekerC , DaoudD , IshayA . Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology2001;57(3):505‐9. LurieY , BreckerC , DaoudD , IshayA , EisenbergE . Lamotrigine in the treatment of painful diabetic neuropathy: a randomized placebo controlled study. Progress in Pain Research and Management2000;16:857‐62. ">Eisenberg 2001</a>; <a href="./references#CD006044-bbs2-0002" title="FinnerupNB , SindrupSH , BachFW , JohannesenIL , JensenTS . Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain2002;96(3):375‐83. [DOI: 10.1016/S0304‐3959(01)00484‐5] ">Finnerup 2002a</a>; <a href="./references#CD006044-bbs2-0004" title="McCleaneG . 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double‐blind, placebo controlled trial. Pain1999;83(1):105‐7. [DOI: 10.1016/S0304‐3959(99)00095‐0] ">McCleane 1999</a>; <a href="./references#CD006044-bbs2-0007" title="SimpsonDM , OlneyR , McArthurJC , KhanA , GodboldJ , Ebel‐FrommerK . A placebo‐controlled trial of lamotrigine for painful HIV‐associated neuropathy. Neurology2000;54(11):2115‐9. ">Simpson 2000</a>; <a href="./references#CD006044-bbs2-0008" title="SimpsonDM , McArthurJC , OlneyR , CliffordD , SoY , RossD , et al. Lamotrigine HIV Neuropathy Study Team. Lamotrigine for HIV‐associated painful sensory neuropathies: a placebo‐controlled trial. Neurology2003;60(9):1508‐14. ">Simpson 2003</a>; <a href="./references#CD006044-bbs2-0009" title="VestergaardK , AndersenG , GottrupH , KristensenBT , JensenTS . Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology2001;56(2):184‐90. ">Vestergaard 2001</a>; <a href="./references#CD006044-bbs2-0012" title="ZakrzewskaJM , ChaudhryZ , NurmikkoTJ , PattonDW , MullensEL . Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double‐blind placebo controlled crossover trial. Pain1997;73(2):223‐30. [DOI: 10.1016/S0304‐3959(97)00104‐8] ">Zakrzewska 1997</a>). In the first update five studies were added (<a href="./references#CD006044-bbs2-0003" title="JoseVM , BhansaliA , HotaD , PandhiP . Randomized double‐blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy. Diabetic Medicine2007; Vol. 24:377‐83. [DOI: 10.1111/j.1464‐5491.2007.02093.x] ">Jose 2007</a>; <a href="./references#CD006044-bbs2-0005" title="RaoRD , FlynnPJ , SloanJA , WongGY , NovotnyP , JohnsonDB , et al. Efficacy of lamotrigine in the management of chemotherapy‐induced peripheral neuropathy: a phase 3 randomized, double‐blind, placebo‐controlled trial, N01C3. Cancer2008; Vol. 112:2802‐8. [DOI: 10.1002/cncr.23482] ">Rao 2008</a>; <a href="./references#CD006044-bbs2-0006" title="NPP30010. A multicenter, randomized, double‐blind, placebo‐controlled, parallel group study to evaluate the safety and efficacy of lamotrigine in subjects with neuropathic pain and inadequate pain relief with gabapentin, tricyclic antidepressants or non‐narcotic analgesics. www.gsk‐clinicalstudyregister.com/ (Accessed 7 August 2013)2005. SilverM , BlumD , GraingerJ , HammerAE , QuessyS . Double‐blind, placebo‐controlled trial of lamotrigine in combination with other medications for neuropathic pain. Journal of Pain and Symptom Management2007; Vol. 34:446‐54. [DOI: 10.1016/j.jpainsymman.2006.12.015] ">Silver 2007</a>; <a href="./references#CD006044-bbs2-0010" title="VinikAI , TuchmanM , SafirsteinB , CorderC , KirbyL , WilksK , et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double‐blind, placebo‐controlled studies. Pain2007; Vol. 128:169‐79. [DOI: 10.1016/j.pain.2006.09.040] ">Vinik 2007a</a>; <a href="./references#CD006044-bbs2-0011" title="VinikAI , TuchmanM , SafirsteinB , CorderC , KirbyL , WilksK , et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double‐blind, placebo‐controlled studies. Pain2007;128:169‐79. [DOI: 10.1016/j.pain.2006.09.040] ">Vinik 2007b</a>), with 1111 participants, almost trebling the number of participants since the previous review. These studies were generally larger in size and of longer duration. We found no new studies for this update that satisfied the inclusion criteria. </p> <p>Twelve previously identified studies (12 publications), involving 1511 participants are therefore included (<a href="./references#CD006044-bbs2-0001" title="EisenbergE , LurieY , BrekerC , DaoudD , IshayA . Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology2001;57(3):505‐9. LurieY , BreckerC , DaoudD , IshayA , EisenbergE . Lamotrigine in the treatment of painful diabetic neuropathy: a randomized placebo controlled study. Progress in Pain Research and Management2000;16:857‐62. ">Eisenberg 2001</a>; <a href="./references#CD006044-bbs2-0002" title="FinnerupNB , SindrupSH , BachFW , JohannesenIL , JensenTS . Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain2002;96(3):375‐83. [DOI: 10.1016/S0304‐3959(01)00484‐5] ">Finnerup 2002a</a>; <a href="./references#CD006044-bbs2-0003" title="JoseVM , BhansaliA , HotaD , PandhiP . Randomized double‐blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy. Diabetic Medicine2007; Vol. 24:377‐83. [DOI: 10.1111/j.1464‐5491.2007.02093.x] ">Jose 2007</a>; <a href="./references#CD006044-bbs2-0004" title="McCleaneG . 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double‐blind, placebo controlled trial. Pain1999;83(1):105‐7. [DOI: 10.1016/S0304‐3959(99)00095‐0] ">McCleane 1999</a>; <a href="./references#CD006044-bbs2-0005" title="RaoRD , FlynnPJ , SloanJA , WongGY , NovotnyP , JohnsonDB , et al. Efficacy of lamotrigine in the management of chemotherapy‐induced peripheral neuropathy: a phase 3 randomized, double‐blind, placebo‐controlled trial, N01C3. Cancer2008; Vol. 112:2802‐8. [DOI: 10.1002/cncr.23482] ">Rao 2008</a>; <a href="./references#CD006044-bbs2-0006" title="NPP30010. A multicenter, randomized, double‐blind, placebo‐controlled, parallel group study to evaluate the safety and efficacy of lamotrigine in subjects with neuropathic pain and inadequate pain relief with gabapentin, tricyclic antidepressants or non‐narcotic analgesics. www.gsk‐clinicalstudyregister.com/ (Accessed 7 August 2013)2005. SilverM , BlumD , GraingerJ , HammerAE , QuessyS . Double‐blind, placebo‐controlled trial of lamotrigine in combination with other medications for neuropathic pain. Journal of Pain and Symptom Management2007; Vol. 34:446‐54. [DOI: 10.1016/j.jpainsymman.2006.12.015] ">Silver 2007</a>; <a href="./references#CD006044-bbs2-0007" title="SimpsonDM , OlneyR , McArthurJC , KhanA , GodboldJ , Ebel‐FrommerK . A placebo‐controlled trial of lamotrigine for painful HIV‐associated neuropathy. Neurology2000;54(11):2115‐9. ">Simpson 2000</a>; <a href="./references#CD006044-bbs2-0008" title="SimpsonDM , McArthurJC , OlneyR , CliffordD , SoY , RossD , et al. Lamotrigine HIV Neuropathy Study Team. Lamotrigine for HIV‐associated painful sensory neuropathies: a placebo‐controlled trial. Neurology2003;60(9):1508‐14. ">Simpson 2003</a>; <a href="./references#CD006044-bbs2-0009" title="VestergaardK , AndersenG , GottrupH , KristensenBT , JensenTS . Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology2001;56(2):184‐90. ">Vestergaard 2001</a>; <a href="./references#CD006044-bbs2-0010" title="VinikAI , TuchmanM , SafirsteinB , CorderC , KirbyL , WilksK , et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double‐blind, placebo‐controlled studies. Pain2007; Vol. 128:169‐79. [DOI: 10.1016/j.pain.2006.09.040] ">Vinik 2007a</a>; <a href="./references#CD006044-bbs2-0011" title="VinikAI , TuchmanM , SafirsteinB , CorderC , KirbyL , WilksK , et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double‐blind, placebo‐controlled studies. Pain2007;128:169‐79. [DOI: 10.1016/j.pain.2006.09.040] ">Vinik 2007b</a>; <a href="./references#CD006044-bbs2-0012" title="ZakrzewskaJM , ChaudhryZ , NurmikkoTJ , PattonDW , MullensEL . Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double‐blind placebo controlled crossover trial. Pain1997;73(2):223‐30. [DOI: 10.1016/S0304‐3959(97)00104‐8] ">Zakrzewska 1997</a>). Two studies were reported in one publication (<a href="./references#CD006044-bbs2-0010" title="VinikAI , TuchmanM , SafirsteinB , CorderC , KirbyL , WilksK , et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double‐blind, placebo‐controlled studies. Pain2007; Vol. 128:169‐79. [DOI: 10.1016/j.pain.2006.09.040] ">Vinik 2007a</a>; <a href="./references#CD006044-bbs2-0011" title="VinikAI , TuchmanM , SafirsteinB , CorderC , KirbyL , WilksK , et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double‐blind, placebo‐controlled studies. Pain2007;128:169‐79. [DOI: 10.1016/j.pain.2006.09.040] ">Vinik 2007b</a>), and an incomplete report of <a href="./references#CD006044-bbs2-0001" title="EisenbergE , LurieY , BrekerC , DaoudD , IshayA . Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology2001;57(3):505‐9. LurieY , BreckerC , DaoudD , IshayA , EisenbergE . Lamotrigine in the treatment of painful diabetic neuropathy: a randomized placebo controlled study. Progress in Pain Research and Management2000;16:857‐62. ">Eisenberg 2001</a> (Lurie 2000) provided no additional data, but is included and linked to the primary study. Additional data for <a href="./references#CD006044-bbs2-0006" title="NPP30010. A multicenter, randomized, double‐blind, placebo‐controlled, parallel group study to evaluate the safety and efficacy of lamotrigine in subjects with neuropathic pain and inadequate pain relief with gabapentin, tricyclic antidepressants or non‐narcotic analgesics. www.gsk‐clinicalstudyregister.com/ (Accessed 7 August 2013)2005. SilverM , BlumD , GraingerJ , HammerAE , QuessyS . Double‐blind, placebo‐controlled trial of lamotrigine in combination with other medications for neuropathic pain. Journal of Pain and Symptom Management2007; Vol. 34:446‐54. [DOI: 10.1016/j.jpainsymman.2006.12.015] ">Silver 2007</a> (NPP30010) were identified during the latest searches in a results summary posted on the GlaxoSmithKline Clinical Trials Register (<a href="#CD006044-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD006044-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD006044-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>Included studies covered the following conditions: central post‐stroke pain (<a href="./references#CD006044-bbs2-0009" title="VestergaardK , AndersenG , GottrupH , KristensenBT , JensenTS . Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology2001;56(2):184‐90. ">Vestergaard 2001</a>), chemotherapy‐induced peripheral neuropathic pain (<a href="./references#CD006044-bbs2-0005" title="RaoRD , FlynnPJ , SloanJA , WongGY , NovotnyP , JohnsonDB , et al. Efficacy of lamotrigine in the management of chemotherapy‐induced peripheral neuropathy: a phase 3 randomized, double‐blind, placebo‐controlled trial, N01C3. Cancer2008; Vol. 112:2802‐8. [DOI: 10.1002/cncr.23482] ">Rao 2008</a>), diabetic neuropathy (<a href="./references#CD006044-bbs2-0001" title="EisenbergE , LurieY , BrekerC , DaoudD , IshayA . Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology2001;57(3):505‐9. LurieY , BreckerC , DaoudD , IshayA , EisenbergE . Lamotrigine in the treatment of painful diabetic neuropathy: a randomized placebo controlled study. Progress in Pain Research and Management2000;16:857‐62. ">Eisenberg 2001</a>; <a href="./references#CD006044-bbs2-0003" title="JoseVM , BhansaliA , HotaD , PandhiP . Randomized double‐blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy. Diabetic Medicine2007; Vol. 24:377‐83. [DOI: 10.1111/j.1464‐5491.2007.02093.x] ">Jose 2007</a>; <a href="./references#CD006044-bbs2-0010" title="VinikAI , TuchmanM , SafirsteinB , CorderC , KirbyL , WilksK , et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double‐blind, placebo‐controlled studies. Pain2007; Vol. 128:169‐79. [DOI: 10.1016/j.pain.2006.09.040] ">Vinik 2007a</a>; <a href="./references#CD006044-bbs2-0011" title="VinikAI , TuchmanM , SafirsteinB , CorderC , KirbyL , WilksK , et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double‐blind, placebo‐controlled studies. Pain2007;128:169‐79. [DOI: 10.1016/j.pain.2006.09.040] ">Vinik 2007b</a>) HIV‐related neuropathy (<a href="./references#CD006044-bbs2-0007" title="SimpsonDM , OlneyR , McArthurJC , KhanA , GodboldJ , Ebel‐FrommerK . A placebo‐controlled trial of lamotrigine for painful HIV‐associated neuropathy. Neurology2000;54(11):2115‐9. ">Simpson 2000</a>; <a href="./references#CD006044-bbs2-0008" title="SimpsonDM , McArthurJC , OlneyR , CliffordD , SoY , RossD , et al. Lamotrigine HIV Neuropathy Study Team. Lamotrigine for HIV‐associated painful sensory neuropathies: a placebo‐controlled trial. Neurology2003;60(9):1508‐14. ">Simpson 2003</a>), mixed neuropathic pain (<a href="./references#CD006044-bbs2-0004" title="McCleaneG . 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double‐blind, placebo controlled trial. Pain1999;83(1):105‐7. [DOI: 10.1016/S0304‐3959(99)00095‐0] ">McCleane 1999</a>; <a href="./references#CD006044-bbs2-0006" title="NPP30010. A multicenter, randomized, double‐blind, placebo‐controlled, parallel group study to evaluate the safety and efficacy of lamotrigine in subjects with neuropathic pain and inadequate pain relief with gabapentin, tricyclic antidepressants or non‐narcotic analgesics. www.gsk‐clinicalstudyregister.com/ (Accessed 7 August 2013)2005. SilverM , BlumD , GraingerJ , HammerAE , QuessyS . Double‐blind, placebo‐controlled trial of lamotrigine in combination with other medications for neuropathic pain. Journal of Pain and Symptom Management2007; Vol. 34:446‐54. [DOI: 10.1016/j.jpainsymman.2006.12.015] ">Silver 2007</a>), spinal cord injury‐related pain (<a href="./references#CD006044-bbs2-0002" title="FinnerupNB , SindrupSH , BachFW , JohannesenIL , JensenTS . Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain2002;96(3):375‐83. [DOI: 10.1016/S0304‐3959(01)00484‐5] ">Finnerup 2002a</a>), and trigeminal neuralgia (<a href="./references#CD006044-bbs2-0012" title="ZakrzewskaJM , ChaudhryZ , NurmikkoTJ , PattonDW , MullensEL . Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double‐blind placebo controlled crossover trial. Pain1997;73(2):223‐30. [DOI: 10.1016/S0304‐3959(97)00104‐8] ">Zakrzewska 1997</a>). There were no studies using lamotrigine to treat fibromyalgia. </p> <p>Eleven studies used a placebo comparator, and one (<a href="./references#CD006044-bbs2-0003" title="JoseVM , BhansaliA , HotaD , PandhiP . Randomized double‐blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy. Diabetic Medicine2007; Vol. 24:377‐83. [DOI: 10.1111/j.1464‐5491.2007.02093.x] ">Jose 2007</a>) used amitriptyline as the comparator. Two studies added lamotrigine or placebo to existing treatments for neuropathic pain (<a href="./references#CD006044-bbs2-0006" title="NPP30010. A multicenter, randomized, double‐blind, placebo‐controlled, parallel group study to evaluate the safety and efficacy of lamotrigine in subjects with neuropathic pain and inadequate pain relief with gabapentin, tricyclic antidepressants or non‐narcotic analgesics. www.gsk‐clinicalstudyregister.com/ (Accessed 7 August 2013)2005. SilverM , BlumD , GraingerJ , HammerAE , QuessyS . Double‐blind, placebo‐controlled trial of lamotrigine in combination with other medications for neuropathic pain. Journal of Pain and Symptom Management2007; Vol. 34:446‐54. [DOI: 10.1016/j.jpainsymman.2006.12.015] ">Silver 2007</a>; <a href="./references#CD006044-bbs2-0012" title="ZakrzewskaJM , ChaudhryZ , NurmikkoTJ , PattonDW , MullensEL . Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double‐blind placebo controlled crossover trial. Pain1997;73(2):223‐30. [DOI: 10.1016/S0304‐3959(97)00104‐8] ">Zakrzewska 1997</a>). The studies included participants in the age range of 26 to 77 years. One study was for two weeks (<a href="./references#CD006044-bbs2-0012" title="ZakrzewskaJM , ChaudhryZ , NurmikkoTJ , PattonDW , MullensEL . Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double‐blind placebo controlled crossover trial. Pain1997;73(2):223‐30. [DOI: 10.1016/S0304‐3959(97)00104‐8] ">Zakrzewska 1997</a>); the remainder were at least six weeks, and eight were of eight‐week duration or longer. Four were cross‐over studies (<a href="./references#CD006044-bbs2-0002" title="FinnerupNB , SindrupSH , BachFW , JohannesenIL , JensenTS . Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain2002;96(3):375‐83. [DOI: 10.1016/S0304‐3959(01)00484‐5] ">Finnerup 2002a</a>; <a href="./references#CD006044-bbs2-0003" title="JoseVM , BhansaliA , HotaD , PandhiP . Randomized double‐blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy. Diabetic Medicine2007; Vol. 24:377‐83. [DOI: 10.1111/j.1464‐5491.2007.02093.x] ">Jose 2007</a>; <a href="./references#CD006044-bbs2-0009" title="VestergaardK , AndersenG , GottrupH , KristensenBT , JensenTS . Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology2001;56(2):184‐90. ">Vestergaard 2001</a>; <a href="./references#CD006044-bbs2-0012" title="ZakrzewskaJM , ChaudhryZ , NurmikkoTJ , PattonDW , MullensEL . Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double‐blind placebo controlled crossover trial. Pain1997;73(2):223‐30. [DOI: 10.1016/S0304‐3959(97)00104‐8] ">Zakrzewska 1997</a>). Details of all eligible studies are given in the <a href="./references#CD006044-sec-0102" title="">Characteristics of included studies</a> table and results for individual studies are in a separate table (<a href="./appendices#CD006044-sec-0091">Appendix 5</a>). </p> </section> <section id="CD006044-sec-0056"> <h4 class="title">Excluded studies</h4> <p>Eleven studies were excluded from the earlier review (<a href="./references#CD006044-bbs2-0013" title="BonicalziV , CanaveroS , CeruttiF , PiazzaM , ClementeM , ChioA . Lamotrigine reduces total postoperative analgesic requirement: a randomized double‐blind, placebo‐controlled pilot study. Surgery1997;122(3):567‐70. [DOI: 10.1016/S0039‐6060(97)90129‐X] ">Bonicalzi 1997</a>; <a href="./references#CD006044-bbs2-0014" title="BreuerB , PappagalloM , KnotkovaH , GuleyupogluN , WallensteinS , PortenoyRK . A randomized, double‐blind, placebo‐controlled, two‐period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis. Clinical Therapeutics2007; Vol. 29:2022‐30. [DOI: 10.1016/j.clinthera.2007.09.023] ">Breuer 2007</a>; <a href="./references#CD006044-bbs2-0015" title="CarrieriPB , ProviteraVV , LavorgnaL , BrunoR . Response of thalamic pain syndrome to lamotrigine. European Journal of Neurology1998;5(6):625‐6. ">Carrieri 1998</a>; <a href="./references#CD006044-bbs2-0016" title="DevulderJ , DeLaatM . Lamotrigine in the treatment of chronic refractory neuropathic pain. Journal of Pain Symptom Management2000;19(5):398‐403. [DOI: 10.1016/S0885‐3924(00)00131‐7] ">Devulder 2000</a>; <a href="./references#CD006044-bbs2-0017" title="DiVadiPP , HamannW . The use of lamotrigine in neuropathic pain. Anaesthesia1998;53(8):808‐9. [DOI: 10.1046/j.1365‐2044.1998.00564.x] ">Di Vadi 1998</a>; <a href="./references#CD006044-bbs2-0018" title="EisenbergE , AlonN , IshayA , DaoudD , YarnitskyD . Lamotrigine in the treatment of painful diabetic neuropathy. European Journal of Neurology1998;5(2):167‐73. [DOI: 10.1046/j.1468‐1331.1998.520167.x] ">Eisenberg 1998</a>; <a href="./references#CD006044-bbs2-0019" title="EisenbergE , DamunniG , HofferE , BaumY , KrivoyN . Lamotrigine for intractable sciatica: correlation between dose, plasma concentration and analgesia. European Journal of Pain2003;7(6):485‐91. [DOI: 10.1016/S1090‐3801(03)00020‐X] ">Eisenberg 2003</a>; <a href="./references#CD006044-bbs2-0020" title="EisenbergE , ShifrinA , KrivoyN . Lamotrigine for neuropathic pain. Expert Review of Neurotherapeutics2005; Vol. 5:729‐35. [DOI: 10.1586/14737175.5.6.729] ">Eisenberg 2005</a>; <a href="./references#CD006044-bbs2-0021" title="LunardiG , LeandriM , AlbanoC , CultreraS , FracassiM , RubinoV , et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology1997;48(6):1714‐7. ">Lunardi 1997</a>; <a href="./references#CD006044-bbs2-0022" title="PetersenKL , MaloneyA , HokeF , DahlJB , RowbothamMC . A randomized study of the effect of oral lamotrigine and hydromorphone on pain and hyperalgesia following heat/capsaicin sensitization. Journal of Pain2003;4(7):400‐6. ">Petersen 2003</a>; <a href="./references#CD006044-bbs2-0023" title="Sandner‐KieslingA , Rumpold SeitlingerG , DornC , KochH , SchwarzG . Lamotrigine monotherapy for control of neuralgia after nerve section. Acta Anaesthesiologica Scandinavica2002;46(10):1261‐4. [DOI: 10.1034/j.1399‐6576.2002.461014.x] ">Sandner‐Kiesling 2002</a>), and one more for this update (<a href="./references#CD006044-bbs2-0024" title="ShaikhS , YaacobHB , Abd RahmanRB . Lamotrigine for trigeminal neuralgia: efficacy and safety in comparison with carbamazepine. Journal of the Chinese Medical Association2011;74(6):243‐9. [DOI: 10.1016/j.jcma.2011.04.002] ">Shaikh 2011</a>). Details of the reasons for exclusion are in the <a href="./references#CD006044-sec-0103" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD006044-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p>Each study was scored for quality using the three‐item Oxford Quality Score scale (<a href="./references#CD006044-bbs2-0045" title="JadadAR , MooreRA , CarrollD , JenkinsonC , ReynoldsDJM , GavaghanDJ , et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials1996;17(1):1‐12. [DOI: 10.1016/0197‐2456(95)00134‐4] ">Jadad 1996</a>) and agreed by the review authors. All scored 3/5 or greater, with one scoring 3/5, five scoring 4/5, and six scoring 5/5. </p> <p>In this update we have used the 'Risk of bias' tool. The comments on individual studies are reported in the Risk of bias section of the <a href="./references#CD006044-sec-0102" title="">Characteristics of included studies</a> table. The findings are displayed in <a href="#CD006044-fig-0002">Figure 2</a>; no sensitivity analysis was undertaken. The greatest risks of bias came from imputation after study withdrawal, outcomes used of little relevance, and small study size. </p> <div class="figure" id="CD006044-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006044-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> </section> <section id="CD006044-sec-0058"> <h3 class="title" id="CD006044-sec-0058">Effects of interventions</h3> <p>See: <a href="./full#CD006044-tbl-0001"><b>Summary of findings for the main comparison</b> Lamotrigine 200 to 400 mg versus placebo for neuropathic pain</a> </p> <p>For measures of efficacy we considered each condition separately, but for adverse outcomes we combined data across conditions. There were no data for fibromyalgia. </p> <section id="CD006044-sec-0059"> <h4 class="title">Efficacy</h4> <p>No study provided first‐tier evidence for an efficacy outcome. We judged results as second‐ or third‐tier because of use of LOCF imputation or completer analysis, and small size. Details of efficacy outcomes in individual studies are in <a href="./appendices#CD006044-sec-0091">Appendix 5</a>. </p> <section id="CD006044-sec-0060"> <h5 class="title">Painful diabetic neuropathy (PDN)</h5> <section id="CD006044-sec-0061"> <h6 class="title">Second tier evidence</h6> <p>Four studies (<a href="./references#CD006044-bbs2-0001" title="EisenbergE , LurieY , BrekerC , DaoudD , IshayA . Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology2001;57(3):505‐9. LurieY , BreckerC , DaoudD , IshayA , EisenbergE . Lamotrigine in the treatment of painful diabetic neuropathy: a randomized placebo controlled study. Progress in Pain Research and Management2000;16:857‐62. ">Eisenberg 2001</a>; <a href="./references#CD006044-bbs2-0003" title="JoseVM , BhansaliA , HotaD , PandhiP . Randomized double‐blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy. Diabetic Medicine2007; Vol. 24:377‐83. [DOI: 10.1111/j.1464‐5491.2007.02093.x] ">Jose 2007</a>; <a href="./references#CD006044-bbs2-0010" title="VinikAI , TuchmanM , SafirsteinB , CorderC , KirbyL , WilksK , et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double‐blind, placebo‐controlled studies. Pain2007; Vol. 128:169‐79. [DOI: 10.1016/j.pain.2006.09.040] ">Vinik 2007a</a>; <a href="./references#CD006044-bbs2-0011" title="VinikAI , TuchmanM , SafirsteinB , CorderC , KirbyL , WilksK , et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double‐blind, placebo‐controlled studies. Pain2007;128:169‐79. [DOI: 10.1016/j.pain.2006.09.040] ">Vinik 2007b</a>) looked at the role of lamotrigine for PDN (758 participants). None of these demonstrated any major benefits. </p> <p>In one study (<a href="./references#CD006044-bbs2-0001" title="EisenbergE , LurieY , BrekerC , DaoudD , IshayA . Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology2001;57(3):505‐9. LurieY , BreckerC , DaoudD , IshayA , EisenbergE . Lamotrigine in the treatment of painful diabetic neuropathy: a randomized placebo controlled study. Progress in Pain Research and Management2000;16:857‐62. ">Eisenberg 2001</a>), a 50% reduction in pain measured in the last three weeks of treatment was reported by 12/27 on lamotrigine titrated up to 400 mg daily and 5/26 on placebo. In two large randomised studies of lamotrigine 200 mg to 400 mg daily, with a 12‐week maintenance phase, there was no difference between lamotrigine and placebo for the outcome of at least 50% pain relief (<a href="./references#CD006044-bbs2-0010" title="VinikAI , TuchmanM , SafirsteinB , CorderC , KirbyL , WilksK , et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double‐blind, placebo‐controlled studies. Pain2007; Vol. 128:169‐79. [DOI: 10.1016/j.pain.2006.09.040] ">Vinik 2007a</a>; <a href="./references#CD006044-bbs2-0011" title="VinikAI , TuchmanM , SafirsteinB , CorderC , KirbyL , WilksK , et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double‐blind, placebo‐controlled studies. Pain2007;128:169‐79. [DOI: 10.1016/j.pain.2006.09.040] ">Vinik 2007b</a>). Combining these studies, 145/567 (26%) of participants experienced at least 50% pain relief with lamotrigine 200 mg to 400 mg daily, and 50/206 (24%) with placebo. There was no overall significant difference between lamotrigine and placebo (RR 1.1 (95% CI 0.8 to 1.4)) (<a href="#CD006044-fig-0003">Figure 3</a>). A similar non‐significant difference was found for participants reporting "marked improvement". </p> <div class="figure" id="CD006044-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Painful diabetic neuropathy, outcome: 1.1 50% pain relief." data-id="CD006044-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Painful diabetic neuropathy, outcome: 1.1 50% pain relief.</p> </div> </div> </div> <p>In the fourth study, a 20% reduction in pain after six weeks of treatment was reported by 19/46 taking lamotrigine 200 mg daily and 13/46 taking 50 mg amitriptyline at night (<a href="./references#CD006044-bbs2-0003" title="JoseVM , BhansaliA , HotaD , PandhiP . Randomized double‐blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy. Diabetic Medicine2007; Vol. 24:377‐83. [DOI: 10.1111/j.1464‐5491.2007.02093.x] ">Jose 2007</a>). There were insufficient data for analysis. </p> </section> </section> <section id="CD006044-sec-0062"> <h5 class="title">Mixed neuropathic pain</h5> <section id="CD006044-sec-0063"> <h6 class="title">Third tier evidence</h6> <p>One study of 100 participants examined the use of lamotrigine 200 mg daily in participants with intractable neuropathic pain diagnosed by symptoms of shooting/lancinating pain, burning, numbness, allodynia and paraesthesia/dysaesthesia (<a href="./references#CD006044-bbs2-0004" title="McCleaneG . 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double‐blind, placebo controlled trial. Pain1999;83(1):105‐7. [DOI: 10.1016/S0304‐3959(99)00095‐0] ">McCleane 1999</a>). At least three of these symptoms were required for participation. Participants already taking an antiepileptic were excluded. No useful analgesic benefit was demonstrated. There was a reduction in the overall pain score of 1/100 mm. </p> <p>A second study used an 'add‐on' design for lamotrigine titrated up to 400 mg daily on top of gabapentin, tricyclic antidepressant, or non‐opioid analgesic where pain was inadequately controlled (<a href="./references#CD006044-bbs2-0006" title="NPP30010. A multicenter, randomized, double‐blind, placebo‐controlled, parallel group study to evaluate the safety and efficacy of lamotrigine in subjects with neuropathic pain and inadequate pain relief with gabapentin, tricyclic antidepressants or non‐narcotic analgesics. www.gsk‐clinicalstudyregister.com/ (Accessed 7 August 2013)2005. SilverM , BlumD , GraingerJ , HammerAE , QuessyS . Double‐blind, placebo‐controlled trial of lamotrigine in combination with other medications for neuropathic pain. Journal of Pain and Symptom Management2007; Vol. 34:446‐54. [DOI: 10.1016/j.jpainsymman.2006.12.015] ">Silver 2007</a>). No additional analgesic benefit could be demonstrated over 14 weeks using responder definitions of ≥ 50% and ≥ 30% pain reduction or PGIC outcomes of much or very much improved. </p> </section> </section> <section id="CD006044-sec-0064"> <h5 class="title">Central post‐stroke pain</h5> <section id="CD006044-sec-0065"> <h6 class="title">Third tier evidence</h6> <p>Thirty participants took part in a single cross‐over study, and only 20 completed both arms (<a href="./references#CD006044-bbs2-0009" title="VestergaardK , AndersenG , GottrupH , KristensenBT , JensenTS . Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology2001;56(2):184‐90. ">Vestergaard 2001</a>). The difference between lamotrigine 200 mg and placebo for clinical response was significant when assessed at eight weeks. Lower pain scores (reduction of 2/10 or more) were reported by 12 participants with lamotrigine and three with placebo. </p> </section> </section> <section id="CD006044-sec-0066"> <h5 class="title">Chemotherapy‐induced peripheral neuropathic pain</h5> <section id="CD006044-sec-0067"> <h6 class="title">Third tier evidence</h6> <p>In a study of 125 participants (<a href="./references#CD006044-bbs2-0005" title="RaoRD , FlynnPJ , SloanJA , WongGY , NovotnyP , JohnsonDB , et al. Efficacy of lamotrigine in the management of chemotherapy‐induced peripheral neuropathy: a phase 3 randomized, double‐blind, placebo‐controlled trial, N01C3. Cancer2008; Vol. 112:2802‐8. [DOI: 10.1002/cncr.23482] ">Rao 2008</a>), average pain scores decreased in both the active and placebo groups with no significant difference between the groups. The study authors concluded that lamotrigine was not effective in this condition. </p> </section> </section> <section id="CD006044-sec-0068"> <h5 class="title">HIV‐related neuropathy</h5> <section id="CD006044-sec-0069"> <h6 class="title">Third tier evidence</h6> <p>There were two studies involving participants with HIV‐related neuropathy. The first study of 42 participants (<a href="./references#CD006044-bbs2-0007" title="SimpsonDM , OlneyR , McArthurJC , KhanA , GodboldJ , Ebel‐FrommerK . A placebo‐controlled trial of lamotrigine for painful HIV‐associated neuropathy. Neurology2000;54(11):2115‐9. ">Simpson 2000</a>) claimed effectiveness for lamotrigine 300 mg/day, but over 50% of the treatment group dropped out, making results difficult to interpret. The second study (<a href="./references#CD006044-bbs2-0008" title="SimpsonDM , McArthurJC , OlneyR , CliffordD , SoY , RossD , et al. Lamotrigine HIV Neuropathy Study Team. Lamotrigine for HIV‐associated painful sensory neuropathies: a placebo‐controlled trial. Neurology2003;60(9):1508‐14. ">Simpson 2003</a>) analysed the results according to whether participants were receiving antiretroviral therapy (ART) or not. For those who were receiving antiretroviral therapy there did appear to be some benefits in terms of attainment of moderate or better pain relief with lamotrigine (35/62, 57%) than with placebo (7/30, 23%); for PGIC, marked improvement was recorded by 29/62 (47%) of participants with lamotrigine and 4/30 (13%) with placebo. </p> </section> </section> <section id="CD006044-sec-0070"> <h5 class="title">Spinal cord injury related pain</h5> <section id="CD006044-sec-0071"> <h6 class="title">Third tier evidence</h6> <p>Thirty participants with neuropathic pain following traumatic spinal cord injury were included (<a href="./references#CD006044-bbs2-0002" title="FinnerupNB , SindrupSH , BachFW , JohannesenIL , JensenTS . Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain2002;96(3):375‐83. [DOI: 10.1016/S0304‐3959(01)00484‐5] ">Finnerup 2002a</a>). Doses of up to 400 mg daily for lamotrigine were used but the study authors reported no significant difference from placebo for the outcomes of ≥ 50% or ≥ 30% pain relief. </p> </section> </section> <section id="CD006044-sec-0072"> <h5 class="title">Trigeminal neuralgia</h5> <section id="CD006044-sec-0073"> <h6 class="title">Third tier evidence</h6> <p>Fourteen participants participated in a cross‐over 'add‐on' study comparing lamotrigine with placebo in a cross‐over study of two two‐week phases separated by a three‐day long washout (<a href="./references#CD006044-bbs2-0012" title="ZakrzewskaJM , ChaudhryZ , NurmikkoTJ , PattonDW , MullensEL . Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double‐blind placebo controlled crossover trial. Pain1997;73(2):223‐30. [DOI: 10.1016/S0304‐3959(97)00104‐8] ">Zakrzewska 1997</a>). All participants continued on carbamazepine or phenytoin throughout the study period. Lamotrigine was not significantly more effective than placebo in this small study; 10/13 participants stated that lamotrigine was better or much better, compared with 8/14 on placebo, using a global evaluation. </p> </section> </section> </section> <section id="CD006044-sec-0074"> <h4 class="title">Adverse events</h4> <p>Adverse events were not consistently reported across studies. Seven studies, with 1121 participants (<a href="./references#CD006044-bbs2-0001" title="EisenbergE , LurieY , BrekerC , DaoudD , IshayA . Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology2001;57(3):505‐9. LurieY , BreckerC , DaoudD , IshayA , EisenbergE . Lamotrigine in the treatment of painful diabetic neuropathy: a randomized placebo controlled study. Progress in Pain Research and Management2000;16:857‐62. ">Eisenberg 2001</a>; <a href="./references#CD006044-bbs2-0002" title="FinnerupNB , SindrupSH , BachFW , JohannesenIL , JensenTS . Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain2002;96(3):375‐83. [DOI: 10.1016/S0304‐3959(01)00484‐5] ">Finnerup 2002a</a>; <a href="./references#CD006044-bbs2-0006" title="NPP30010. A multicenter, randomized, double‐blind, placebo‐controlled, parallel group study to evaluate the safety and efficacy of lamotrigine in subjects with neuropathic pain and inadequate pain relief with gabapentin, tricyclic antidepressants or non‐narcotic analgesics. www.gsk‐clinicalstudyregister.com/ (Accessed 7 August 2013)2005. SilverM , BlumD , GraingerJ , HammerAE , QuessyS . Double‐blind, placebo‐controlled trial of lamotrigine in combination with other medications for neuropathic pain. Journal of Pain and Symptom Management2007; Vol. 34:446‐54. [DOI: 10.1016/j.jpainsymman.2006.12.015] ">Silver 2007</a>; <a href="./references#CD006044-bbs2-0009" title="VestergaardK , AndersenG , GottrupH , KristensenBT , JensenTS . Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology2001;56(2):184‐90. ">Vestergaard 2001</a>; <a href="./references#CD006044-bbs2-0010" title="VinikAI , TuchmanM , SafirsteinB , CorderC , KirbyL , WilksK , et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double‐blind, placebo‐controlled studies. Pain2007; Vol. 128:169‐79. [DOI: 10.1016/j.pain.2006.09.040] ">Vinik 2007a</a>; <a href="./references#CD006044-bbs2-0011" title="VinikAI , TuchmanM , SafirsteinB , CorderC , KirbyL , WilksK , et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double‐blind, placebo‐controlled studies. Pain2007;128:169‐79. [DOI: 10.1016/j.pain.2006.09.040] ">Vinik 2007b</a>; <a href="./references#CD006044-bbs2-0012" title="ZakrzewskaJM , ChaudhryZ , NurmikkoTJ , PattonDW , MullensEL . Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double‐blind placebo controlled crossover trial. Pain1997;73(2):223‐30. [DOI: 10.1016/S0304‐3959(97)00104‐8] ">Zakrzewska 1997</a>) reported the number of participants who experienced at least one adverse event. Combining the studies across conditions, 531/740 (72%) of participants had an adverse event with lamotrigine and 237/381 (62%) with placebo. The RR just reached statistical significance at 1.1 (1.01 to 1.2) (<a href="./references#CD006044-fig-0006" title="">Analysis 2.1</a>) and the NNH was 10 (6.5 to 27). </p> <p>Rash can be problematic with lamotrigine. It was mentioned as an adverse event or adverse event withdrawal in 11 studies, and omitted from a long list of adverse events in the other (<a href="./references#CD006044-bbs2-0012" title="ZakrzewskaJM , ChaudhryZ , NurmikkoTJ , PattonDW , MullensEL . Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double‐blind placebo controlled crossover trial. Pain1997;73(2):223‐30. [DOI: 10.1016/S0304‐3959(97)00104‐8] ">Zakrzewska 1997</a>). Combining studies, the overall incidence of rash was 9.5% with lamotrigine and 5.6% with placebo, barely achieving statistical significance (RR 1.4 (1.01 to 2.0)) (<a href="#CD006044-fig-0004">Figure 4</a>). This would indicate that rash with lamotrigine would affect about one person in 27 who would not have been affected with placebo. </p> <div class="figure" id="CD006044-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 All conditions: lamotrigine versus placebo, outcome: 2.2 Rash." data-id="CD006044-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 All conditions: lamotrigine versus placebo, outcome: 2.2 Rash. </p> </div> </div> </div> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006044-sec-0075" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006044-sec-0075"></div> <p>Antiepileptic drugs have been used in the treatment of neuropathic pain since lamotrigine was first used for trigeminal neuralgia in the 1960s. Other antiepileptic drugs have been examined, with good evidence of efficacy for gabapentin (<a href="./references#CD006044-bbs2-0067" title="MooreRA , WiffenPJ , DerryS , McQuayHJ . Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2011, Issue 3. [DOI: 10.1002/14651858.CD007938.pub2] ">Moore 2011a</a>) and pregabalin (<a href="./references#CD006044-bbs2-0061" title="MooreRA , StraubeS , WiffenPJ , DerryS , McQuayHJ . Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] ">Moore 2009a</a>), and these two are now widely used. Although various drugs may be useful in controlling seizures, they have different mechanisms of action. There is no reason why a drug effective at seizure control should necessarily be effective in treating neuropathic pain. Lamotrigine, a relatively new antiepileptic drug, has therefore been investigated in neuropathic painful conditions. </p> <section id="CD006044-sec-0076"> <h3 class="title" id="CD006044-sec-0076">Summary of main results</h3> <p>Large, high‐quality, long‐duration studies reporting clinically useful levels of pain relief for individual participants provide no convincing evidence that lamotrigine is effective in treating neuropathic pain and fibromyalgia at doses of about 200 mg to 400 mg daily. There is very limited evidence for a possible effect of lamotrigine in central post‐stroke pain and in a subgroup of patients with HIV‐related neuropathy receiving antiretroviral therapy. No benefit was demonstrated for diabetic neuropathy, in intractable neuropathic pain, spinal cord injury, or trigeminal neuralgia. We found no studies testing lamotrigine in fibromyalgia. The small number of studies and the small number of participants are insufficient to provide robust evidence for effect. </p> <p>Safety is an important aspect of the choice of treatment even in difficult conditions. In this review, about 10% of participants developed a rash; this fits with wider epidemiological work (<a href="./references#CD006044-bbs2-0044" title="HirschLJ , WeintraubDB , BuchsbaumR , SpencerHT , StrakaT , HagerM , et al. Predictors of lamotrigine‐associated rash. Epilepsia2006;47(2):318‐22. [DOI: 10.1111/j.1528‐1167.2006.00423.x] ">Hirsch 2006</a>). The results are consistent with reports in the manufacturer's summary of product characteristics. Serious potentially life‐threatening rashes such as Stevens Johnson Syndrome are estimated to occur at an incidence of 1 in 1000 (<a href="./references#CD006044-bbs2-0080" title="Summary of product characteristics for Lamictal. Section 4.8. www.medicines.org.uk Accessed 8 August 2013. ">SPC 2013</a>). </p> </section> <section id="CD006044-sec-0077"> <h3 class="title" id="CD006044-sec-0077">Overall completeness and applicability of evidence</h3> <p>The difficulties of dose titration and adverse effects are likely to dissuade many clinicians from choosing lamotrigine to treat neuropathic pain, and it is possible that those conducting the studies have chosen to include the more difficult participants in terms of severity and duration of pain. </p> <p>Efficacy and adverse event outcomes were not consistently reported across the studies, and this limited the analyses to some extent. </p> </section> <section id="CD006044-sec-0078"> <h3 class="title" id="CD006044-sec-0078">Quality of the evidence</h3> <p>The studies included in this review covered a number of different painful conditions. For some, like HIV neuropathy for instance, it is unclear whether antiepileptic drugs are effective in the condition, and any indication of benefit is welcome. The main quality issues involve reporting of outcomes of interest, particularly dichotomous outcomes equivalent to Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT), as well as better reporting of adverse events. The earliest study was published in 1997, and there have been major changes in clinical trial reporting since then. The studies themselves appear to be largely well‐conducted, and individual patient analysis could overcome some of the shortcomings of reporting, though not the paucity of participants studied in each neuropathic pain condition. </p> </section> <section id="CD006044-sec-0079"> <h3 class="title" id="CD006044-sec-0079">Potential biases in the review process</h3> <p>The review was restricted to randomised double‐blind studies, thus limiting the potential for bias. Other possible sources of bias that could have affected the review included: </p> <p> <ul id="CD006044-list-0009"> <li> <p>Duration ‐ NNT estimates of efficacy in chronic pain studies tend to increase (get worse) with increasing duration (<a href="./references#CD006044-bbs2-0066" title="MooreRA , MooreOA , DerryS , PelosoPM , GammaitoniAR , WangH . Responder analysis for pain relief and numbers needed to treat in a meta‐analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases2010;69(2):374‐9. [DOI: 10.1136/ard.2009.107805] ">Moore 2010d</a>). However, all studies were six weeks or longer, and most longer than eight weeks. </p> </li> <li> <p>Outcomes may affect estimates of efficacy, but the efficacy outcomes chosen were of participants achieving the equivalent of IMMPACT‐defined moderate or substantial improvement, and it is likely that lesser benefits, such as 'any benefit' or 'any improvement', are potentially related to inferior outcomes, though this remains to be clarified. Most authors attempted to report dichotomous outcomes of interest, especially in the larger, more recent studies. </p> </li> <li> <p>The question of whether cross‐over trials exaggerate treatment effects in comparison with parallel‐group designs, as has been seen in some circumstances (<a href="./references#CD006044-bbs2-0050" title="KhanKS , DayaS , JadadA . The importance of quality of primary studies in producing unbiased systematic reviews. Archives of Internal Medicine1996;156(6):661‐6. ">Khan 1996</a>), is unclear but unlikely to be the source of major bias (<a href="./references#CD006044-bbs2-0036" title="ElbourneDR , AltmanDG , HigginsJP , CurtinF , WorthingtonHV , VailA . Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology2002;31(1):140‐9. [DOI: 10.1093/ije/31.1.140] ">Elbourne 2002</a>). Withdrawals meant that any results were more likely to be per protocol for completers than for a true ITT analysis. Parallel group studies were larger than cross‐over studies, and predominated analyses in terms of number of participants, with only about 100 participants in cross‐over studies. </p> </li> <li> <p>The absence of publication bias (unpublished trials showing no benefit of lamotrigine over placebo) can never be proven. However, publication bias is irrelevant where the published studies show no effect of treatment. </p> </li> <li> <p>Imputation methods used when participants withdrew were typically either last observation carried forward (LOCF) or were not stated; no study reported clearly that participants achieving acceptable levels of pain relief were unequivocally on treatment at the end of the study. Use of LOCF imputation can overestimate efficacy, particularly where adverse event withdrawals are high with active treatment (<a href="./references#CD006044-bbs2-0071" title="MooreRA , StraubeS , EcclestonC , DerryS , AldingtonD , WiffenP , et al. Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain2012;153(2):265‐8. [DOI: 10.1016/j.pain.2011.10.004] ">Moore 2012b</a>). </p> </li> </ul> </p> </section> <section id="CD006044-sec-0080"> <h3 class="title" id="CD006044-sec-0080">Agreements and disagreements with other studies or reviews</h3> <p>This update does not substantially change the results of the 2011 update, which itself was broadly in agreement with the previous Cochrane review (<a href="./references#CD006044-bbs2-0093" title="WiffenPJ , ReesJ . Lamotrigine for acute and chronic pain. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD006044.pub2] ">Wiffen 2007</a>). </p> <p>A systematic review of pharmacological treatment of painful HIV‐associated sensory neuropathy (<a href="./references#CD006044-bbs2-0076" title="PhillipsTJ , CherryCL , CoxS , MarshallSJ , RiceAS . Pharmacological treatment of painful HIV‐associated sensory neuropathy: a systematic review and meta‐analysis of randomised controlled trials. PLoS One2010;5(12):e14433. [DOI: 10.1371/journal.pone.0014433] ">Phillips 2010</a>) did not find lamotrigine 600 mg/day to be better than placebo. A non‐systematic review considered lamotrigine to be effective, but based on only a fraction of the results presented in this updated review (<a href="./references#CD006044-bbs2-0046" title="JensenTS . Anticonvulsants in neuropathic pain: rationale and clinical evidence. European Journal of Pain2002;6(Suppl A):61‐8. [DOI: 10.1053/eujp.2001.0324] ">Jensen 2002</a>), and <a href="./references#CD006044-bbs2-0037" title="FinnerupNB , GottrupH , JensenTS . Anticonvulsants in central pain. Expert Opinions in Pharmacotherapy2002;3(10):1411‐20. [DOI: 10.1517/14656566.3.10.1411] ">Finnerup 2002b</a> suggested that lamotrigine is as good as amitriptyline and is a first‐line agent in central neuropathic pain. </p> <p>Guidelines from Europe (<a href="./references#CD006044-bbs2-0026" title="AttalN , CruccuG , BaronR , HaanpääM , HanssonP , JensenTS , et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European Journal of Neurology2010;17(9):1113‐e88. [DOI: 10.1111/j.1468‐1331.2010.02999.x] ">Attal 2010</a>) and the International Association for the Study of Pain (<a href="./references#CD006044-bbs2-0035" title="DworkinRH , O'ConnorAB , AudetteJ , BaronR , GourlayGK , HaanpääML , et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clinic Proceedings2010;85(3 Suppl):S3‐14. [DOI: 10.4065/mcp.2009.0649] ">Dworkin 2010</a>) reported that there were few data for lamotrigine in any neuropathic pain condition, and recommended its use only as a third line medication, and probably only in a specialist setting. Guidelines from NICE in the UK do not recommend lamotrigine for neuropathic pain (<a href="./references#CD006044-bbs2-0074" title="NICE clinical guideline 173. Neuropathic pain – pharmacological management. www.nice.org.uk/guidance/CG173 (accessed 26 November 2013)2013:1‐138. ">NICE 2013</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006044-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/urn:x-wiley:14651858:media:CD006044:CD006044-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_t/tCD006044-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD006044-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/full#CD006044-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006044-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/urn:x-wiley:14651858:media:CD006044:CD006044-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_t/tCD006044-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006044-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/full#CD006044-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006044-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/urn:x-wiley:14651858:media:CD006044:CD006044-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_t/tCD006044-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Painful diabetic neuropathy, outcome: 1.1 50% pain relief." data-id="CD006044-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Painful diabetic neuropathy, outcome: 1.1 50% pain relief.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/full#CD006044-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006044-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/urn:x-wiley:14651858:media:CD006044:CD006044-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_t/tCD006044-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 All conditions: lamotrigine versus placebo, outcome: 2.2 Rash." data-id="CD006044-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 All conditions: lamotrigine versus placebo, outcome: 2.2 Rash. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/full#CD006044-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006044-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/urn:x-wiley:14651858:media:CD006044:CD006044-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_t/tCD006044-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Painful diabetic neuropathy: lamotrigine versus placebo, Outcome 1 50% pain relief." data-id="CD006044-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Painful diabetic neuropathy: lamotrigine versus placebo, Outcome 1 50% pain relief. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/references#CD006044-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006044-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/urn:x-wiley:14651858:media:CD006044:CD006044-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_t/tCD006044-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 All conditions: lamotrigine versus placebo, Outcome 1 At least one adverse event." data-id="CD006044-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 All conditions: lamotrigine versus placebo, Outcome 1 At least one adverse event. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/references#CD006044-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006044-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/urn:x-wiley:14651858:media:CD006044:CD006044-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_t/tCD006044-CMP-002-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 All conditions: lamotrigine versus placebo, Outcome 2 Rash." data-id="CD006044-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 All conditions: lamotrigine versus placebo, Outcome 2 Rash.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/references#CD006044-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/media/CDSR/CD006044/image_n/nCD006044-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006044-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Lamotrigine 200 to 400 mg versus placebo for neuropathic pain</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Lamotrigine compared with placebo for painful diabetic neuropathy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: neuropathic pain (three studies in painful diabetic neuropathy)</b> </p> <p><b>Settings: Community</b> </p> <p><b>Intervention: oral lamotrigine 200 to 400 mg daily</b> </p> <p><b>Comparison: placebo</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Probable outcome with</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Risk ratio</b> </p> <p><b>NNTor NNH</b> </p> <p><b>(95% CI)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of studies, attacks, events</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>comparator</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>intervention</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At least 50% of maximum pain relief</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>240 in 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>260 in 1000</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.1 (0.82 to 1.4)</p> <p>NNT not calculated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 studies, 773 participants, 195 events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unlikely that further research would reveal significant benefit, especially as potential high positive bias exists in the calculations we have because of LOCF imputation or completer analyses </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants with at least 1 adverse event (all conditions)</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>622 in 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>717 in 1000</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.1 (1.01 to 1.2)</p> <p>NNH 10 (6.5 to 27)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 studies, 1121 participants, 768 events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Large numbers of events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants with a serious adverse event (all conditions)</p> </td> <td align="center" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants with rash (all conditions)</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>56 in 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>95 in 1000</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.4 (1.01 to 2.0)</p> <p>NNH 27 (16 to 89)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 studies, 1715 participants, 138 events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modest number of events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Deaths (all conditions)</p> </td> <td align="center" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>LOCF: last observation carried forward; NNT: number needed to treat for an additional beneficial outcome: NNH: number needed to treat for an additional harmful outcome; RR: risk ratio </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Lamotrigine 200 to 400 mg versus placebo for neuropathic pain</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/full#CD006044-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006044-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Painful diabetic neuropathy: lamotrigine versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 50% pain relief <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>773</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.82, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Painful diabetic neuropathy: lamotrigine versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/references#CD006044-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006044-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">All conditions: lamotrigine versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 At least one adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [1.01, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Rash <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1715</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [1.01, 2.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">All conditions: lamotrigine versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006044.pub4/references#CD006044-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006044.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD006044-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006044-note-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD006044-note-0001">Hrvatski</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD006044-note-0006">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006044\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006044\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006044\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006044\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006044\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006044\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006044\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006044\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006044\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006044\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006044\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006044\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006044\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006044\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006044\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006044\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006044\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006044\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6XSHdtL3&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006044.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006044.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006044.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006044.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006044.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740720302236"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006044.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740720302239"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006044.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dfdd63ce29377',t:'MTc0MDcyMDMwMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 